Cramp and spasm

R18_CRAMP_SPASM

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — R25.2 Cause of death: ICD-10 — R25.2 2 out of 7 registries used, show all original rules.	2137
4. Check minimum number of events None	2137
5. Include endpoints None	2137
6. Filter based on genotype QC (FinnGen only)	1906

Control definitions (FinnGen only)

Control exclude: CD2_BENIGN_FEMALE_GEN_OTH

Extra metadata

Level in the ICD hierarchy: 4
Special: MUSCLECRAMPS
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: R25
Name in latin: Crampus

NAME	R18_CRAMP_SPASM
CONTROL_EXCLUDE	CD2_BENIGN_FEMALE_GEN_OTH
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	R252
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	R252
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Cramp and spasm based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1906	1088	818
Unadjusted period prevalence (%)	0.38	0.39	0.38
Median age at first event (years)	54.67	51.48	58.93

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1976: Matched controls
19760

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R25.2

ICD-10 Finland

Cramp and spasm

+∞

307.7

1976

122

N03AE01

ATC

clonazepam; systemic

8.6

257.9

365

505

R56.8

ICD-10 Finland

Other and unspecified convulsions

7.7

199.3

305

457

N03AX12

ATC

[U] gabapentin; oral

3.6

129.2

539

1849

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.7

129.1

345

859

N03AX16

ATC

[U] pregabalin

3.3

126.3

689

2787

AA1AD

NOMESCO Finland

CT of head and brain

2.8

103.4

763

3584

M03BX01

ATC

baclofen; systemic

8.3

91.8

124

158

R51.80

ICD-10 Finland

Headache

3.0

90.2

507

2035

R25.3

ICD-10 Finland

Fasciculation

32.6

88.2

N05BA01

ATC

diazepam; systemic, rectal

3.3

88.0

398

1406

N04BC05

ATC

pramipexole; oral

4.0

80.7

253

700

M79.6

ICD-10 Finland

Pain in limb

2.4

80.2

1078

6536

R07.4

ICD-10 Finland

Chest pain, unspecified

2.5

77.8

716

3650

M03BC01

ATC

orphenadrine (citrate); systemic

2.6

75.8

609

2907

G40.9

ICD-10 Finland

Epilepsy, unspecified

5.6

75.2

148

280

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.4

75.1

923

5334

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.3

72.6

319

1099

N03AF02

ATC

oxcarbazepine; oral

5.5

71.3

143

275

M03BX02

ATC

tizanidine; oral

2.5

71.3

1404

9853

N03AG01

ATC

valproic acid; systemic, rectal

4.0

70.9

216

584

M79.1

ICD-10 Finland

Myalgia

2.8

70.6

455

1938

N02AX02

ATC

tramadol; systemic, rectal

2.3

70.6

993

6031

N06AX21

ATC

duloxetine; oral

3.0

69.8

372

1431

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

4.0

69.0

213

581

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.3

67.1

1060

6707

G24.9

ICD-10 Finland

Dystonia, unspecified

24.0

65.6

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

4.2

65.3

184

469

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.1

64.6

314

1144

R53

ICD-10 Finland

Malaise and fatigue

2.3

64.0

655

3445

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.9

64.0

358

1410

R42

ICD-10 Finland

Dizziness and giddiness

2.4

62.1

561

2789

A01

ICPC

Pain general/multiple sites

3.0

61.2

309

1148

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.3

60.5

617

3227

J45.9

ICD-10 Finland

Asthma, unspecified

2.5

60.5

496

2356

M54.5

ICD-10 Finland

Low back pain

2.2

60.1

891

5421

A02BC02

ATC

pantoprazole; systemic

2.3

59.2

1456

10777

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.3

59.0

676

3705

T36

ICD-10 Finland

Poisoning by systemic antibiotics

4.3

58.6

162

406

R55

ICD-10 Finland

Syncope and collapse

2.9

57.0

299

1132

N02BF01

ATC

gabapentin; oral

2.9

56.9

305

1169

XF400

NOMESCO Finland

ECG with 12 standard connections

2.6

54.5

382

1677

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.6

53.8

187

551

R20.2

ICD-10 Finland

Paraesthesia of skin

3.2

53.8

231

779

Z3231

NOMESCO Finland

Registered nurse

2.2

53.7

635

3501

L17

ICPC

Foot/toe symptom/complaint

2.1

53.6

728

4237

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.3

53.0

489

2431

N05BA04

ATC

oxazepam; oral

2.2

52.8

625

3443

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

12.1

52.5

N05AH04

ATC

quetiapine; oral

2.4

52.3

473

2330

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.4

51.7

465

2283

N06AX11

ATC

mirtazapine; oral

2.1

50.9

784

4763

N03AX09

ATC

lamotrigine; oral

3.6

50.4

175

515

R52.9

ICD-10 Finland

Pain, unspecified

2.8

49.6

292

1171

R11

ICD-10 Finland

Nausea and vomiting

2.9

49.4

257

965

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.4

48.9

407

1927

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.9

48.4

248

923

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.5

47.7

345

1530

R07.3

ICD-10 Finland

Other chest pain

2.7

47.5

289

1178

R52.2

ICD-10 Finland

Other chronic pain

4.1

47.2

136

351

N03AX14

ATC

levetiracetam; systemic

4.8

46.6

107

231

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.8

46.1

262

1030

R25.1

ICD-10 Finland

Tremor, unspecified

4.8

46.1

108

237

S06.0

ICD-10 Finland

Concussion

2.6

45.7

302

1281

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.4

45.5

372

1742

TAB00

NOMESCO Finland

Lumbar puncture

3.7

45.3

151

432

XA800

NOMESCO Finland

Neuropsychological investigation

3.7

44.3

146

414

R06.0

ICD-10 Finland

Dyspnoea

2.1

44.0

614

3559

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.6

43.6

290

1233

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.3

43.1

382

1850

H02AB06

ATC

prednisolone; systemic

1.9

43.0

1003

6915

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

3.2

42.8

184

618

X59

ICD-10 Finland

Exposure to unspecified factor

2.2

42.6

469

2480

M25.5

ICD-10 Finland

Pain in joint

1.9

42.3

769

4875

N02BF02

ATC

pregabalin; oral

3.0

41.9

199

708

N02BE01

ATC

paracetamol; systemic, rectal

3.1

41.7

1821

15683

L01

ICPC

Neck symptom/complaint

2.2

41.2

411

2088

N17

ICPC

Vertigo/dizziness

2.4

40.8

317

1446

G72.9

ICD-10 Finland

Myopathy, unspecified

9.1

40.8

R4120

NOMESCO Finland

Occupational therapy

3.0

40.5

190

671

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

40.3

936

6397

N05CF01

ATC

zopiclone; oral

2.0

40.0

666

4082

N06AA09

ATC

amitriptyline; systemic

2.7

39.8

229

904

L28

ICPC

Limited function/disability (L)

2.2

39.7

411

2115

A02BC05

ATC

esomeprazole; systemic

1.9

39.2

846

5633

G44.2

ICD-10 Finland

Tension-type headache

2.3

38.9

343

1651

M54.4

ICD-10 Finland

Lumbago with sciatica

2.1

38.8

443

2366

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

38.6

660

4069

L03

ICPC

Low back symptom/complaint

1.9

38.6

672

4168

N06AX16

ATC

venlafaxine; oral

2.2

38.0

365

1819

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.9

38.0

193

712

R4110

NOMESCO Finland

Physiotherapy

2.0

37.8

602

3621

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

5.4

37.6

143

Z3226

NOMESCO Finland

Physiotherapist

2.1

37.5

410

2152

Z71.8

ICD-10 Finland

Other specified counselling

1.9

37.2

776

5090

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.3

37.1

339

1654

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.1

36.4

440

2396

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.3

35.9

320

1545

R02

ICPC

Shortness of breath/dyspnoea

2.3

35.8

323

1566

N03AF01

ATC

carbamazepine; oral, rectal

3.3

35.7

141

449

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

4.9

35.5

170

C07AA05

ATC

propranolol; systemic

2.0

35.5

473

2666

N01

ICPC

Headache

2.3

35.1

314

1517

X58

ICD-10 Finland

Exposure to other specified factors

2.1

34.6

375

1956

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

34.5

553

3315

A04

ICPC

Weakness/tiredness general

2.1

34.1

381

2008

A02BC01

ATC

omeprazole; systemic

1.9

34.1

564

3414

N05AH03

ATC

olanzapine; systemic

2.8

33.9

187

720

J01FF01

ATC

clindamycin; systemic

1.9

33.9

578

3534

N02AA05

ATC

oxycodone; systemic

2.1

33.9

382

2021

JN3AD

NOMESCO Finland

Abdominal CT examination

2.3

33.7

305

1478

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.4

33.7

268

1229

WX892

NOMESCO Finland

Monitored bed care

2.7

33.7

197

782

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

33.3

919

6495

C07AB07

ATC

bisoprolol; oral

1.8

33.3

914

6450

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.2

33.2

141

469

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

33.1

444

2501

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.5

32.7

228

985

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.6

32.7

212

885

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

32.7

477

2765

R96

ICPC

Asthma

2.4

32.5

239

1058

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

5.1

32.3

136

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.7

32.3

107

304

N06AB04

ATC

citalopram; systemic

2.0

31.8

440

2501

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

31.8

720

4788

L12

ICPC

Hand/finger symptom/complaint

2.0

31.6

404

2232

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

4.9

31.5

147

A28

ICPC

Limited function/disability NOS

2.1

31.4

351

1846

A11

ICPC

Chest pain NOS

2.5

31.3

208

878

S18

ICPC

Laceration/cut

1.7

31.3

958

6934

Z2221

NOMESCO Finland

Medical doctor

1.8

31.2

579

3619

Z2445

NOMESCO Finland

Psychologist

3.2

30.7

124

400

A29

ICPC

General symptom/complaint other

2.2

30.3

304

1532

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.4

30.2

221

975

Z2446

NOMESCO Finland

Social worker

2.7

30.2

174

685

XF600

NOMESCO Finland

Bloodpressure measurement

2.8

30.1

159

598

R00.2

ICD-10 Finland

Palpitations

2.5

30.0

208

895

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.2

29.9

278

1359

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.4

29.9

228

1025

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

29.7

493

2968

M01AB05

ATC

diclofenac; systemic, rectal

1.8

29.6

1308

10414

M54.8

ICD-10 Finland

Other dorsalgia

3.1

29.5

131

447

WX002

NOMESCO Finland

Sedation and analgesia

2.0

29.4

402

2268

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

4.3

29.3

185

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.3

29.3

247

1159

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.0

29.1

403

2283

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

29.1

510

3121

S21

ICPC

Skin texture symptom/complaint

2.0

28.7

340

1823

D01

ICPC

Abdominal pain/cramps general

2.1

28.6

304

1566

N06AB10

ATC

escitalopram; oral

1.9

28.5

466

2789

D06

ICPC

Abdominal pain localized other

2.4

28.3

217

977

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.6

28.2

283

R03AC02

ATC

salbutamol; inhalant

1.7

28.1

1132

8729

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.4

28.1

217

980

M48.0

ICD-10 Finland

Spinal stenosis

2.2

28.1

257

1247

ZXD05

NOMESCO Finland

Urgent procedure

1.8

28.0

620

4064

J01DB01

ATC

cefalexin; oral

2.0

27.8

1661

14326

R03DC03

ATC

montelukast; oral

2.0

27.8

375

2103

M79.7

ICD-10 Finland

Fibromyalgia

3.5

27.5

297

L19

ICPC

Muscle symptom/complaint NOS

3.6

27.4

269

N03AX11

ATC

topiramate; oral

3.9

27.3

213

P19

ICPC

Drug abuse

6.7

27.3

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.4

27.2

192

832

R33

ICD-10 Finland

Retention of urine

2.5

26.4

173

724

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.8

26.4

555

3573

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.1

26.3

300

1583

R06.4

ICD-10 Finland

Hyperventilation

4.9

26.1

118

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

26.1

548

3525

A02BC03

ATC

lansoprazole; oral

1.8

26.0

552

3562

R50.9

ICD-10 Finland

Fever, unspecified

2.0

25.9

345

1922

A06AD11

ATC

lactulose; oral

2.1

25.9

280

1448

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.7

25.7

639

4307

ZY010

NOMESCO Finland

Hospital outpatient

2.7

25.6

143

553

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.3

25.6

221

1046

K30

ICD-10 Finland

Functional dyspepsia

2.1

25.5

261

1321

K59.09

ICD-10 Finland

Constipation, unspecified

2.6

25.5

157

638

T78.4

ICD-10 Finland

Allergy, unspecified

2.9

25.1

122

438

L86

ICPC

Back syndrome with radiating pain

2.6

25.0

156

637

L02

ICPC

Back symptom/complaint

2.1

24.9

252

1269

XA402

NOMESCO Finland

ENMG

4.0

24.9

186

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

24.9

611

4095

N30.0

ICD-10 Finland

Acute cystitis

1.9

24.8

360

2062

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

24.7

327

1816

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

3.1

24.6

105

350

J45.1

ICD-10 Finland

Nonallergic asthma

2.5

24.6

168

717

R06AE07

ATC

cetirizine; oral

1.6

24.5

885

6549

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.0

24.4

297

1601

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

24.2

849

6231

R60.0

ICD-10 Finland

Localized oedema

2.1

23.8

261

1354

H53.1

ICD-10 Finland

Subjective visual disturbances

2.4

23.8

166

715

J02AC01

ATC

fluconazole; systemic

1.6

23.8

762

5462

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.3

23.6

149

N05AA02

ATC

levomepromazine; systemic

3.1

23.6

102

343

H57.1

ICD-10 Finland

Ocular pain

2.9

23.5

111

392

TKC20

NOMESCO Finland

Catheterisation of bladder

2.6

23.5

146

595

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

3.6

23.5

227

M54.3

ICD-10 Finland

Sciatica

2.6

23.2

141

569

M03BC51

ATC

orphenadrine, combinations; systemic

1.7

23.2

544

3590

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.3

23.1

284

P01AB01

ATC

metronidazole; oral, rectal

1.6

23.1

784

5688

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.4

23.1

264

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.4

23.0

169

745

A03FA01

ATC

metoclopramide; systemic, rectal

1.8

22.8

442

2763

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

22.8

680

4776

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

22.7

710

5044

UJF32

NOMESCO Finland

Coloscopy

1.7

22.6

495

3201

ZXE00

NOMESCO Finland

One hour or less

1.6

22.5

752

5425

N05CD07

ATC

temazepam; oral

2.2

22.5

217

1072

M54.6

ICD-10 Finland

Pain in thoracic spine

2.3

22.4

185

857

J01FA06

ATC

roxithromycin; oral

1.6

22.4

759

5494

ZXA05

NOMESCO Finland

Left side

1.8

22.4

451

2848

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.2

22.3

212

1040

R03BB04

ATC

tiotropium bromide; inhalant

2.2

22.3

207

1006

XF402

NOMESCO Finland

ECG with work load test

2.2

22.3

207

1007

F10.20

ICD-10 Finland

Alcohol dependence currently independent

4.1

22.2

156

C03CA01

ATC

furosemide; systemic

1.7

22.1

501

3268

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.9

22.1

108

389

N05BA09

ATC

clobazam; oral

7.4

22.1

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.4

22.0

159

695

M54.2

ICD-10 Finland

Cervicalgia

2.2

21.9

194

926

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.6

21.8

209

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

4.4

21.8

124

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.8

21.7

113

421

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.7

21.5

117

446

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.6

21.5

134

547

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

21.4

325

1882

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

21.4

313

1792

N05AX12

ATC

aripiprazole; systemic

2.8

21.4

112

419

H02AB07

ATC

prednisone; oral

2.0

21.3

267

1450

XF404

NOMESCO Finland

Ambulatory ECG

2.3

21.3

178

829

R05

ICPC

Cough

1.7

21.2

518

3442

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.6

21.0

205

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

20.8

933

7175

R51

ICD-10 Finland

Headache

2.4

20.8

144

618

J01AA02

ATC

doxycycline; systemic

1.7

20.6

1470

12584

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

20.5

1438

12245

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

20.4

487

3211

N07

ICPC

Convulsion/seizure

22.6

20.4

S29

ICPC

Skin symptom/complaint other

1.7

20.3

413

2606

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

20.3

251

1356

P06

ICPC

Sleep disturbance

1.9

20.3

292

1660

F29

ICPC

Eye symptom/complaint other

2.0

20.3

230

1205

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.6

20.3

195

N06AB03

ATC

fluoxetine; oral

1.9

20.2

261

1431

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.7

20.1

497

3307

R01AD09

ATC

mometasone; nasal

1.6

20.0

903

6934

G43.3

ICD-10 Finland

Complicated migraine

3.9

20.0

155

R25.8

ICD-10 Finland

Other and unspecified abnormal involuntary movements

19.0

20.0

J01MA02

ATC

ciprofloxacin; systemic

1.6

19.9

723

5283

G43.9

ICD-10 Finland

Migraine, unspecified

2.3

19.9

154

694

J01EA01

ATC

trimethoprim; systemic

1.7

19.8

472

3107

R13

ICD-10 Finland

Dysphagia

2.3

19.8

159

728

K08.80

ICD-10 Finland

Toothache NOS

2.1

19.8

211

1081

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.1

19.7

201

1012

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

19.7

416

2652

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

6.5

19.7

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

4.0

19.6

139

M01AH01

ATC

celecoxib; oral

1.8

19.6

330

1970

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.9

19.6

264

1469

M35.7

ICD-10 Finland

Hypermobility syndrome

4.5

19.4

106

R03BA01

ATC

beclometasone; inhalant

1.9

19.4

271

1526

L04

ICPC

Chest symptom/complaint

2.3

19.3

153

696

R03BA05

ATC

fluticasone; inhalant

1.8

19.3

368

2278

R03AC03

ATC

terbutaline; inhalant

1.9

19.1

281

1608

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

19.1

1038

8273

R03BA02

ATC

budesonide; inhalant

1.8

19.0

364

2255

ZXD35

NOMESCO Finland

Usual procedure

3.1

19.0

265

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.0

19.0

281

S80.0

ICD-10 Finland

Contusion of knee

2.2

18.9

176

856

P18

ICPC

Medication abuse

5.8

18.9

J45

ICD-10 Finland

Asthma

2.0

18.8

222

1179

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

4.5

18.7

101

R52.1

ICD-10 Finland

Chronic intractable pain

5.6

18.7

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.0

18.7

203

1047

W19

ICD-10 Finland

Unspecified fall

2.0

18.6

210

1097

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

18.6

598

4234

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.0

18.5

216

1143

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.1

18.5

178

877

K07.60

ICD-10 Finland

Snapping jaw

2.4

18.4

130

562

ZX120

NOMESCO Finland

Intravenous

2.1

18.4

189

954

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

18.4

1436

12347

D11

ICPC

Diarrhoea

1.9

18.4

266

1513

P29

ICPC

Psychological sympt/compl other

2.1

18.4

187

941

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

3.8

18.4

146

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.2

18.3

171

833

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

5.4

18.3

J46

ICD-10 Finland

Status asthmaticus

3.2

18.2

225

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.3

18.1

148

682

N07BB01

ATC

disulfiram; oral

2.7

18.1

102

396

N05BA02

ATC

chlordiazepoxide; systemic

3.5

18.0

186

C01CA24

ATC

epinephrine; parenteral

2.2

18.0

156

737

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

3.0

17.9

285

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

17.8

546

3814

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

17.8

283

1657

A03

ICPC

Fever

1.7

17.8

375

2382

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

4.8

17.8

SPAT1216

SPAT

Assessment of functional ability

1.8

17.7

275

1599

R21

ICPC

Throat symptom/complaint

1.6

17.7

453

3028

F51.0

ICD-10 Finland

Nonorganic insomnia

1.7

17.7

373

2370

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.9

17.6

248

1398

L18

ICPC

Muscle pain

2.6

17.5

101

397

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

17.4

1071

8689

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.9

17.4

284

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

4.1

17.4

120

P99

ICPC

Psychological disorders other

2.9

17.3

296

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.0

17.3

197

1033

R51.81

ICD-10 Finland

Facial pain NOS

3.3

17.2

207

N06AB06

ATC

sertraline; oral

1.9

17.1

256

1471

B01AB05

ATC

enoxaparin; parenteral

1.6

17.1

564

4003

L14

ICPC

Leg/thigh symptom/complaint

2.1

17.0

173

870

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.6

17.0

103

415

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

17.0

336

2096

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.8

16.9

293

1758

WVA20

NOMESCO Finland

Medicine administration

3.0

16.9

256

A99

ICPC

Disease/condition unspecnature/site

1.9

16.9

223

1230

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.5

16.8

105

429

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.8

16.8

137

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.1

16.8

168

840

P15

ICPC

Chronic alcohol abuse

2.9

16.7

285

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.0

16.7

205

1102

E0000UV, ,

ATC

1.5

16.7

802

6166

R60.9

ICD-10 Finland

Oedema, unspecified

2.4

16.7

118

511

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.1

16.7

160

787

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.1

16.7

237

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

16.6

1040

8435

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

4.1

16.6

111

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.4

16.6

120

525

N06AG02

ATC

moclobemide; oral

2.7

16.6

349

L08

ICPC

Shoulder symptom/complaint

1.6

16.6

449

3038

L13

ICPC

Hip symptom/complaint

1.7

16.5

356

2270

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

5.6

16.5

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

4.0

16.5

116

L29

ICPC

Musculoskeletal sympt/complt other

2.0

16.5

186

971

P01

ICPC

Feeling anxious/nervous/tense

1.8

16.5

291

1756

S22.3

ICD-10 Finland

Fracture of rib

2.1

16.5

159

784

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

3.1

16.4

234

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

5.4

16.4

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

5.7

16.3

G24.8

ICD-10 Finland

Other dystonia

14.4

16.3

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

14.4

16.3

SPAT1301

SPAT

No procedures

1.6

16.3

567

4064

D02

ICPC

Abdominal pain epigastric

2.2

16.3

138

646

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.9

16.3

262

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.2

16.3

148

713

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.8

16.2

248

1434

UKC02

NOMESCO Finland

Cystoscopy

1.8

16.1

281

1688

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

4.7

16.1

M54.1

ICD-10 Finland

Radiculopathy

2.6

16.1

360

U02

ICPC

Urinary frequency/urgency

1.8

16.1

287

1736

ZXA00

NOMESCO Finland

Right side

1.6

16.1

453

3090

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

16.1

148

716

N88

ICPC

Epilepsy

6.0

16.1

F44.4

ICD-10 Finland

Dissociative motor disorders

47.9

16.0

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.8

15.9

242

1395

ZYC01

NOMESCO Finland

Remote contact by phone

2.2

15.9

141

673

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

6.4

15.8

G81.9

ICD-10 Finland

Hemiplegia, unspecified

5.2

15.8

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.0

15.8

194

1044

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.4

15.7

114

499

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.9

15.7

256

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.2

15.7

132

616

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.7

15.7

307

D25

ICPC

Abdominal distension

3.4

15.7

168

XQ800

NOMESCO Finland

Prick test

2.1

15.6

162

821

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.4

15.5

108

464

A27

ICPC

Fear of other disease NOS

2.4

15.5

111

483

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

15.5

382

2520

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

15.4

206

1141

R35

ICD-10 Finland

Polyuria

2.2

15.3

137

655

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.9

15.3

118

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

4.3

15.3

ZX114

NOMESCO Finland

Intramuscular

4.1

15.3

105

N03AX18

ATC

lacosamide; systemic

5.5

15.3

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

3.4

15.2

161

R01AD08

ATC

fluticasone; nasal

1.5

15.2

542

3894

G40

ICD-10 Finland

Epilepsy

4.9

15.2

N06AX03

ATC

mianserin; oral

2.5

15.2

407

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.8

15.2

230

1324

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

15.1

417

2826

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

3.3

15.1

172

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

3.1

15.1

208

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

4.0

15.1

106

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.8

15.1

246

1449

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.1

15.0

147

728

M01AH05

ATC

etoricoxib; oral

1.5

15.0

1184

9964

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

15.0

230

1329

S04

ICPC

Lump/swelling localized

1.8

15.0

230

1329

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.3

15.0

111

491

SPAT1254

SPAT

Administration of medicine

1.7

14.9

272

1656

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.8

14.8

287

N05BA06

ATC

lorazepam; systemic, sublingual

2.4

14.8

105

456

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.0

14.7

227

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.7

14.7

317

R49.8

ICD-10 Finland

Other and unspecified voice disturbances

4.8

14.7

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.9

14.7

202

1127

L15

ICPC

Knee symptom/complaint

1.6

14.7

477

3354

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

14.7

415

2826

R06AX27

ATC

desloratadine; oral

1.5

14.6

574

4204

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.0

14.6

159

819

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

14.6

132

634

F10.24

ICD-10 Finland

Alcohol depence active use

3.7

14.6

127

R4110, ,

SPAT

1.8

14.6

260

1571

N30.9

ICD-10 Finland

Cystitis, unspecified

2.2

14.6

132

635

R05

ICD-10 Finland

Cough

1.6

14.5

417

2850

N06AX26

ATC

vortioxetine; oral

2.0

14.5

171

907

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.8

14.4

225

1306

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.0

14.4

151

767

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.9

14.4

241

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

14.4

342

2232

A07AA02

ATC

nystatin; oral

2.3

14.4

111

500

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.1

14.3

146

734

A02BA02

ATC

ranitidine; systemic

1.7

14.3

327

2112

R1250

NOMESCO Finland

Evaluation of functional capability

3.0

14.3

220

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

14.3

786

6153

N05BE01

ATC

buspirone; oral

2.8

14.3

253

R74

ICPC

Upper respiratory infection acute

1.5

14.3

674

5121

R49.08

ICD-10 Finland

Other specified dysphonia

3.2

14.3

178

Z01.2

ICD-10 Finland

Dental examination

1.4

14.3

909

7316

M01AE02

ATC

naproxen; oral, rectal

1.4

14.2

1080

8980

ZXA10

NOMESCO Finland

Bilateral

1.7

14.2

319

2052

Y04.8

ICD-10 Finland

Assault by bodily force by other known person

6.5

14.1

U01

ICPC

Dysuria/painful urination

2.0

14.1

163

858

WX402

NOMESCO Finland

General anaesthesia

1.6

14.1

437

3037

N99

ICPC

Neurological disease other

4.3

14.1

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

14.1

712

5480

XKD00

NOMESCO Finland

Uroflowmetry

1.7

14.1

261

1594

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.3

14.0

109

492

G24.3

ICD-10 Finland

Spasmodic torticollis

4.6

14.0

M02AA10

ATC

ketoprofen; topical

1.7

14.0

282

1761

F99

ICD-10 Finland

Mental disorder, not otherwise specified

3.2

14.0

170

L16

ICPC

Ankle symptom/complaint

1.8

13.9

249

1504

N04AA02

ATC

biperiden; systemic

3.5

13.9

136

J01MA12

ATC

levofloxacin; systemic

1.6

13.9

328

2135

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

13.8

213

1232

L20

ICPC

Joint symptom/complaint NOS

2.5

13.8

352

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.5

13.7

347

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.5

13.6

360

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.2

13.6

168

N05BA12

ATC

alprazolam; oral

1.9

13.6

190

1066

N89

ICPC

Migraine

2.4

13.6

410

N04BC04

ATC

ropinirole; oral

5.5

13.5

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.9

13.5

172

936

NF1AA

NOMESCO Finland

Hip X-ray examination

2.0

13.5

162

864

E86

ICD-10 Finland

Volume depletion

3.2

13.5

169

N29

ICPC

Neurological sympt/complt other

3.4

13.4

144

RS221, ,

NOMESCO Finland

3.8

13.4

106

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

13.4

202

1161

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.2

13.3

170

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.5

13.3

340

M77.4

ICD-10 Finland

Metatarsalgia

2.1

13.3

134

672

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

5.4

13.3

WYA10

NOMESCO Finland

Emergency care or similar visit

2.0

13.2

151

791

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.0

13.2

148

770

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

13.2

240

1456

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.2

13.2

166

G04CA02

ATC

tamsulosin; oral

1.6

13.2

382

2610

SPAT1153

SPAT

Removal of sutures

1.5

13.1

542

3996

PA6AD

NOMESCO Finland

CT of neck arteries

2.5

13.1

348

R03AC12

ATC

salmeterol; inhalant

2.5

13.1

348

M01AH02

ATC

rofecoxib; oral

1.8

13.1

213

1251

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

13.1

486

3506

N05AX08

ATC

risperidone; systemic

1.9

13.1

161

866

Z00.0

ICD-10 Finland

General medical examination

1.6

13.1

368

2498

K29

ICPC

Cardiovascular sympt/complt other

2.5

13.0

349

SPAT1263

SPAT

Sampling

1.4

12.9

756

5956

D12

ICPC

Constipation

2.5

12.9

321

S01

ICPC

Pain/tenderness of skin

2.3

12.9

100

452

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

4.7

12.8

G47.3

ICD-10 Finland

Sleep apnoea

1.5

12.8

432

3051

A08

ICPC

Swelling

2.2

12.8

112

531

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

3.9

12.8

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

3.9

12.8

W17

ICD-10 Finland

Other fall from one level to another

2.4

12.8

402

D07AC01

ATC

betamethasone; topical

1.4

12.8

658

5061

R40.2

ICD-10 Finland

Coma, unspecified

5.4

12.8

G25.2

ICD-10 Finland

Other specified forms of tremor

5.4

12.8

K02.1

ICD-10 Finland

Caries of dentine

1.4

12.8

1151

9787

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

12.8

369

2519

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.1

12.7

117

567

C05AA08

ATC

fluocortolone; rectal, topical

1.7

12.7

238

1457

A02BA04

ATC

nizatidine; systemic

2.1

12.6

129

651

SPAT1229

SPAT

Assessment of need for aid

2.0

12.6

130

658

S10

ICPC

Boil/carbuncle

2.1

12.5

123

610

R03AK08

ATC

formoterol and beclometasone; inhalant

2.3

12.5

444

SPAT1240

SPAT

Therapeutic discussion

1.8

12.5

218

1307

F41.00

ICD-10 Finland

Moderate panic disorder

3.4

12.5

131

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.6

12.4

296

D10

ICPC

Vomiting

2.0

12.4

132

674

D09

ICPC

Nausea

2.2

12.4

108

511

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

3.5

12.4

122

N06AA10

ATC

nortriptyline; systemic

3.0

12.4

178

EB1VA, ,

NOMESCO Finland

1.6

12.4

348

2359

E87.6

ICD-10 Finland

Hypokalaemia

2.5

12.4

297

N05CF02

ATC

zolpidem; oral

1.6

12.3

321

2136

Z08

ICPC

Social welfare problem

3.6

12.3

113

XCK00

NOMESCO Finland

Perimetry

2.2

12.3

104

487

H92.0

ICD-10 Finland

Otalgia

2.0

12.2

137

713

R5599

NOMESCO Finland

Other rehabilitation service

2.7

12.2

240

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

9.7

12.2

K59.0

ICD-10 Finland

Constipation

2.2

12.2

109

522

A97

ICPC

No disease

1.5

12.2

381

2645

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

4.4

12.2

P27

ICPC

Fear of mental disorder

3.6

12.1

114

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

6.1

12.1

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

3.0

12.1

186

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

12.1

730

5768

G25.3

ICD-10 Finland

Myoclonus

21.4

12.0

R4130

NOMESCO Finland

Speech therapy

2.7

12.0

237

J01FA09

ATC

clarithromycin; systemic

1.5

12.0

574

4345

J01CA04

ATC

amoxicillin; systemic

1.5

12.0

1584

14367

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

12.0

253

1598

F61.0

ICD-10 Finland

Mixed personality disorders

3.4

11.9

125

C08DB01

ATC

diltiazem; oral

2.4

11.9

339

183

Kela drug reimbursment

Lamotrigin and topiramate

4.9

11.9

K04.08

ICD-10 Finland

Other specified pulpit

1.8

11.9

171

967

R10.0

ICD-10 Finland

Acute abdomen

2.6

11.9

273

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.3

11.9

409

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.1

11.9

115

568

P76

ICPC

Depressive disorder

1.9

11.8

147

793

J01FA10

ATC

azithromycin; systemic

1.4

11.8

1087

9219

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.9

11.8

183

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.4

11.8

366

N06AA12

ATC

doxepin; systemic

2.2

11.7

444

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.6

11.7

252

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.1

11.7

114

565

J45.8

ICD-10 Finland

Mixed asthma

2.6

11.6

258

N05CD08

ATC

midazolam; nasal, systemic

3.0

11.6

174

G44.0

ICD-10 Finland

Cluster headache syndrome

3.8

11.6

C10AX09

ATC

ezetimibe; oral

1.6

11.6

294

1944

H01

ICPC

Ear pain/earache

1.7

11.5

237

1486

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.4

11.5

326

N05AF03

ATC

chlorprothixene; systemic

2.8

11.5

208

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

2.2

11.5

454

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.8

11.5

180

1046

M89.0

ICD-10 Finland

Algoneurodystrophy

4.4

11.5

A92

ICPC

Allergy/allergic reaction NOS

2.4

11.4

321

EBA00

NOMESCO Finland

Extraction of tooth

1.4

11.4

698

5514

R5110, ,

SPAT

1.9

11.4

156

870

M70.6

ICD-10 Finland

Trochanteric bursitis

1.7

11.3

228

1421

SFA20

NOMESCO Finland

Two-surface restoration

1.4

11.3

1118

9564

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.9

11.3

142

769

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

11.3

178

1036

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.9

11.2

140

757

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.3

11.2

349

G56.3

ICD-10 Finland

Lesion of radial nerve

4.8

11.2

J20

ICD-10 Finland

Acute bronchitis

1.7

11.2

199

1199

G41.9

ICD-10 Finland

Status epilepticus, unspecified

5.6

11.2

N04BD02

ATC

rasagiline; oral

5.6

11.2

G43.8

ICD-10 Finland

Other migraine

3.2

11.1

141

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

3.0

11.1

162

H53.2

ICD-10 Finland

Diplopia

2.5

11.1

288

C01DA14

ATC

isosorbide mononitrate; oral

1.7

11.1

219

1357

H02AB04

ATC

methylprednisolone; systemic

1.6

11.1

251

1613

T78.3

ICD-10 Finland

Angioneurotic oedema

3.6

11.0

102

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.2

11.0

422

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

4.0

11.0

NXL00

NOMESCO Finland

Biopsy of muscle

8.6

11.0

R07.0

ICD-10 Finland

Pain in throat

1.9

11.0

150

834

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.4

11.0

333

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.8

11.0

178

1044

J01DA01

ATC

[U] cefalexin

1.4

11.0

1118

9590

ACC53

NOMESCO Finland

Release of ulnar nerve

3.4

11.0

117

M54

ICD-10 Finland

Dorsalgia

1.6

11.0

249

1601

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.1

10.9

104

511

RS222, ,

NOMESCO Finland

4.1

10.9

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

2.0

10.9

117

601

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.0

10.9

119

615

B18.2

ICD-10 Finland

Chronic viral hepatitis C

3.8

10.9

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

10.8

221

1382

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.7

10.8

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.6

10.7

239

M02AA07

ATC

piroxicam; topical

1.4

10.7

576

4437

C03DA01

ATC

spironolactone; oral

1.7

10.7

205

1261

D19

ICPC

Teeth/gum symptom/complaint

1.4

10.7

593

4593

C07AB02

ATC

metoprolol; systemic

1.6

10.6

307

2088

SGA01

NOMESCO Finland

Emergency treatment

1.5

10.6

323

2222

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

10.6

404

2914

S60.0

ICD-10 Finland

Contusion of finger(s) without damage to nail

2.3

10.6

370

J31.0

ICD-10 Finland

Chronic rhinitis

1.8

10.6

167

971

C08DA01

ATC

verapamil; systemic

2.3

10.6

351

C10AA05

ATC

atorvastatin; oral

1.4

10.6

688

5472

N28

ICPC

Limited function/disability (N)

3.2

10.6

130

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

10.6

204

1257

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

10.5

296

2001

-59

ICPC

Other therap proced/minor surg NEC

2.7

10.5

218

P16

ICPC

Acute alcohol abuse

3.1

10.5

146

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.4

10.5

290

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.5

10.5

272

S22

ICPC

Nail symptom/complaint

1.9

10.4

133

724

F44.5

ICD-10 Finland

Dissociative convulsions

110.6

10.4

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.9

10.4

163

U07

ICPC

Urine symptom/complaint other

1.8

10.4

152

864

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.7

10.4

209

1301

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.4

10.4

530

4039

J05AB11

ATC

valaciclovir; oral

1.6

10.4

266

1759

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.3

10.4

367

WX290

NOMESCO Finland

Other blockage of nerve

1.4

10.4

928

7766

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.2

10.4

393

R03BA08

ATC

ciclesonide; inhalant

1.8

10.4

168

985

XA400

NOMESCO Finland

EEG

7.7

10.4

WX320

NOMESCO Finland

Spinalanesthesy

1.5

10.4

432

3172

K92.1

ICD-10 Finland

Melaena

2.1

10.4

460

N18

ICPC

Paralysis/weakness

3.1

10.3

137

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.8

10.3

151

859

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

10.3

151

859

R1250, ,

SPAT

2.5

10.3

274

K10.3

ICD-10 Finland

Alveolitis of jaws

2.1

10.3

103

515

R12

ICD-10 Finland

Heartburn

1.8

10.3

159

919

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.4

10.3

287

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.4

10.3

312

R15

ICD-10 Finland

Faecal incontinence

2.7

10.2

204

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

10.2

195

1198

R01AD58

ATC

fluticasone, combinations; nasal

1.4

10.2

473

3542

WX730

NOMESCO Finland

Conventional respirator

3.4

10.2

103

A01AB09

ATC

miconazole; local oral

1.8

10.1

147

834

N06AX17

ATC

milnacipran; oral

3.9

10.1

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

10.1

103

519

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.9

10.1

166

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.5

10.1

265

F45.8

ICD-10 Finland

Other somatoform disorders

1.8

10.1

140

784

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.0

10.1

150

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.5

10.0

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.7

10.0

177

1065

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.9

10.0

167

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.1

10.0

453

G62.8

ICD-10 Finland

Other specified polyneuropathies

4.1

10.0

R49.01

ICD-10 Finland

Functional dysphonia

2.4

9.9

267

M10.9

ICD-10 Finland

Gout, unspecified

1.9

9.9

122

657

KMAK, ,

NOMESCO Finland

1.4

9.9

943

7951

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

9.8

743

6039

C08CA01

ATC

amlodipine; oral

1.4

9.8

612

4820

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

9.8

230

1488

M75.8

ICD-10 Finland

Other shoulder lesions

2.2

9.8

389

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.1

9.8

136

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

9.8

419

3086

S63.6

ICD-10 Finland

Sprain and strain of finger(s)

2.2

9.8

376

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.1

9.8

490

G40.4

ICD-10 Finland

Other generalized epilepsy and epileptic syndromes

20.1

9.8

G82.5

ICD-10 Finland

Tetraplegia, unspecified

20.1

9.8

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.8

9.8

162

956

K11.71

ICD-10 Finland

Xerostomy (dry mouth)

3.8

9.8

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

4.7

9.8

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.0

9.7

111

582

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.5

9.7

257

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.3

9.7

339

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.4

9.7

276

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

9.7

192

1191

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.6

9.7

210

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

9.7

694

5592

S02

ICPC

Pruritus

2.2

9.7

346

H29

ICPC

Ear symptom/complaint other

1.6

9.7

221

1422

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.8

9.7

144

824

R41.0

ICD-10 Finland

Disorientation, unspecified

2.6

9.7

222

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.7

9.6

193

NA2AD

NOMESCO Finland

Thoracic spine CT examination

5.3

9.6

R04.2

ICD-10 Finland

Haemoptysis

2.4

9.6

277

SFA30

NOMESCO Finland

Three-surface restoration

1.4

9.6

769

6302

N87

ICPC

Parkinsonism

3.8

9.6

Z29

ICPC

Social problem NOS

2.7

9.6

182

K07

ICPC

Swollen ankles/oedema

2.1

9.6

413

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.9

9.6

115

614

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.8

9.6

171

Z03

ICPC

Housing/neighbourhood problem

5.0

9.6

RF220, ,

NOMESCO Finland

3.7

9.5

Z72.2

ICD-10 Finland

Drug use

4.8

9.5

K04.0

ICD-10 Finland

Pulpitis

1.7

9.5

186

1149

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.2

9.5

368

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.2

9.5

355

N05AD01

ATC

haloperidol; systemic

2.6

9.5

212

N06AB05

ATC

paroxetine; oral

1.9

9.5

112

595

K04.1

ICD-10 Finland

Necrosis of pulp

1.6

9.5

208

1325

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

9.5

522

4024

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

9.5

128

711

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.3

9.5

330

R83

ICPC

Respiratory infection other

1.4

9.4

497

3801

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

9.4

398

2924

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

9.4

141

808

XG466

NOMESCO Finland

Sleep oxymetry

2.5

9.4

237

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

4.3

9.4

Z00.8

ICD-10 Finland

Other general examinations

1.8

9.4

153

900

L05

ICPC

Flank/axilla symptom/complaint

1.9

9.3

125

692

F05.9

ICD-10 Finland

Delirium, unspecified

3.0

9.3

135

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

2.8

9.3

157

R39.1

ICD-10 Finland

Other difficulties with micturition

2.4

9.3

257

B01AC04

ATC

clopidogrel; oral

1.6

9.3

251

1681

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

3.8

9.2

A46

ICD-10 Finland

Erysipelas

1.6

9.2

243

1617

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.9

9.2

119

651

R09.1

ICD-10 Finland

Pleurisy

3.0

9.2

136

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

9.2

525

4068

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

9.2

486

3717

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

4.2

9.2

M01AX17

ATC

nimesulide; oral

1.5

9.1

375

2738

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

3.6

9.1

J01CA08

ATC

pivmecillinam; oral

1.4

9.1

682

5521

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.7

9.1

176

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

9.1

205

1315

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.3

9.1

291

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

9.1

365

2656

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.1

9.0

376

M75.5

ICD-10 Finland

Bursitis of shoulder

2.6

9.0

194

-60

ICPC

Result test/procedure

2.0

9.0

102

534

B07.9

ICD-10 Finland

Verruca simplex

2.2

9.0

363

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.5

9.0

230

F10.06

ICD-10 Finland

Alcohol-related acute intoxication with seizures

18.7

8.9

N05AH02

ATC

clozapine; systemic

2.9

8.9

144

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

7.5

8.9

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.7

8.9

179

1114

S01.0

ICD-10 Finland

Open wound of scalp

1.8

8.9

140

814

SPAT1104

SPAT

Monitoring of emergency patient

1.9

8.9

109

586

H81.3

ICD-10 Finland

Other peripheral vertigo

2.5

8.9

225

G04BD12

ATC

mirabegron; oral

1.6

8.9

195

1242

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.2

8.9

339

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.9

8.9

120

667

A05

ICPC

Feeling ill

1.8

8.9

128

726

TAC99

NOMESCO Finland

Other blockade for chronic pain

4.5

8.8

E87.5

ICD-10 Finland

Hyperkalaemia

3.1

8.8

118

G72.8

ICD-10 Finland

Other specified myopathies

3.1

8.8

118

-1, ,

NOMESCO Finland

1.4

8.8

616

4926

SFA10

NOMESCO Finland

One-surface restoration

1.3

8.8

1031

8901

P03

ICPC

Feeling depressed

1.6

8.8

204

1316

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

3.8

8.8

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.6

8.8

185

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.1

8.8

387

WX704

NOMESCO Finland

Intubation

1.7

8.8

147

871

G20

ICD-10 Finland

Parkinson disease

2.6

8.8

191

SPAT1260

SPAT

Consultation of another employee

1.5

8.8

293

2053

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.4

8.8

372

2732

J01MA14

ATC

moxifloxacin; systemic

1.7

8.8

157

948

N05AN01

ATC

lithium; oral

2.6

8.8

203

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

8.8

494

3816

F45.0

ICD-10 Finland

Somatization disorder

7.2

8.7

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

3.7

8.7

IHZ05, ,

SPAT

2.0

8.7

470

M01AE01

ATC

ibuprofen; systemic, rectal

1.5

8.7

1729

16223

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.7

8.7

163

G57.1

ICD-10 Finland

Meralgia paraesthetica

3.1

8.7

114

A07DA03

ATC

loperamide; oral

2.4

8.7

234

XX3XW, ,

NOMESCO Finland

6.6

8.7

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.0

8.6

507

N06AA06

ATC

trimipramine; systemic

2.6

8.6

181

RS121, ,

NOMESCO Finland

4.6

8.6

G83.4

ICD-10 Finland

Cauda equina syndrome

8.2

8.6

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

8.2

8.6

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

2.1

8.6

418

S01.9

ICD-10 Finland

Open wound of head, part unspecified

2.9

8.6

131

J05AB01

ATC

aciclovir; systemic

1.4

8.6

382

2831

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.9

8.6

142

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.6

8.5

187

1190

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.1

8.5

110

R1260

NOMESCO Finland

Evaluation of communicative skills

3.0

8.5

126

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

2.6

8.5

194

G24

ICD-10 Finland

Dystonia

27.6

8.5

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.2

8.5

326

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.8

8.5

115

640

Y96.8

ICD-10 Finland

Other type of accident

4.2

8.5

K04

ICPC

Palpitations/awareness of heart

1.9

8.5

100

532

E000001, ,

ATC

1.4

8.4

347

2532

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

8.4

492

3818

IHZ04, ,

SPAT

2.7

8.4

160

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.2

8.4

320

G25.0

ICD-10 Finland

Essential tremor

2.5

8.4

213

R52.0

ICD-10 Finland

Acute pain

2.2

8.4

314

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

3.5

8.4

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

8.4

250

1710

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

4.5

8.4

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

8.4

986

8497

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.0

8.4

122

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

2.8

8.3

144

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.5

8.3

208

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

2.2

8.3

302

R03AC13

ATC

formoterol; inhalant

2.0

8.3

478

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

3.0

8.3

117

A02BC04

ATC

rabeprazole; oral

1.7

8.3

160

985

Z01.7

ICD-10 Finland

Laboratory examination

1.5

8.3

303

2160

N05AB03

ATC

perphenazine; systemic, rectal

2.2

8.3

309

N80

ICPC

Head injury other

2.6

8.3

173

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

3.6

8.3

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.1

8.3

369

R05FB02

ATC

cough suppressants and expectorants; systemic

1.4

8.3

596

4780

XKC03

NOMESCO Finland

Water cystometry

2.4

8.3

227

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

4.1

8.3

K60.1

ICD-10 Finland

Chronic anal fissure

2.6

8.3

191

G50.1

ICD-10 Finland

Atypical facial pain

2.9

8.2

134

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.2

8.2

317

K08.3

ICD-10 Finland

Retained dental root

1.7

8.2

137

811

N02AC04

ATC

dextropropoxyphene; oral

2.3

8.2

253

A03CA02

ATC

clidinium and psycholeptics; oral

2.0

8.2

432

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.8

8.2

140

N04BD01

ATC

selegiline; oral

3.6

8.1

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.1

8.1

103

-69

ICPC

Other reason for encounter NEC

2.1

8.1

332

M01AC06

ATC

meloxicam; systemic, rectal

1.3

8.1

594

4775

P20

ICPC

Memory disturbance

1.6

8.1

199

1303

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

8.1

213

1417

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

8.1

153

938

AA5PD

NOMESCO Finland

CT examination of brain pefusion

3.8

8.1

N07CA01

ATC

betahistine; oral

1.8

8.1

118

672

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

8.1

382

2859

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.9

8.0

484

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.0

8.0

456

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.8

8.0

120

688

L11

ICPC

Wrist symptom/complaint

1.6

8.0

176

1121

G40.51

ICD-10 Finland

Epileptic seizures related to alcohol

22.1

8.0

S63.5

ICD-10 Finland

Sprain and strain of wrist

2.1

8.0

374

N06AX12

ATC

bupropion; oral

1.7

8.0

144

871

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.1

8.0

388

SPA60

NOMESCO Finland

Fitting of intermediary dental prosthesis structures, 1 to 3 units

3.0

7.9

115

N06AX22

ATC

agomelatine; oral

2.5

7.9

207

M01AH03

ATC

valdecoxib; oral

1.9

7.9

101

551

WX702

NOMESCO Finland

Supraglottic ventilation device

1.9

7.9

103

566

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.5

7.9

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.7

7.9

160

ZY000

NOMESCO Finland

Hospital inpatient

2.9

7.9

121

F01

ICPC

Eye pain

2.3

7.8

271

WZC00, ,

SPAT

1.5

7.8

265

1860

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

3.5

7.8

RS220, ,

NOMESCO Finland

3.2

7.8

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.3

7.8

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.6

7.8

197

1298

L09

ICPC

Arm symptom/complaint

1.9

7.8

504

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

3.0

7.8

111

N08

ICPC

Abnormal involuntary movements

9.4

7.8

K92.0

ICD-10 Finland

Haematemesis

2.5

7.8

185

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.7

7.8

132

786

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.2

7.7

305

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

7.7

422

3233

XA420

NOMESCO Finland

Extensive sleep examination

3.7

7.7

J37.0

ICD-10 Finland

Chronic laryngitis

2.2

7.7

292

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

7.7

105

585

A91

ICPC

Abnormal result investigation NOS

1.9

7.7

101

556

R49.02

ICD-10 Finland

Spasmodic dysphonia

15.1

7.7

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.1

7.7

359

S70.0

ICD-10 Finland

Contusion of hip

2.1

7.7

339

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.8

7.7

106

593

V19

ICD-10 Finland

Pedal cyclist injured in other and unspecified transport accidents

2.5

7.7

186

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.8

7.7

134

SPAT1312

SPAT

General health counselling

1.3

7.6

545

4356

SPAT1097

SPAT

Recording of ECG

1.5

7.6

220

1493

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.5

7.6

187

L29.9

ICD-10 Finland

Pruritus, unspecified

2.3

7.6

262

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.4

7.6

218

P74

ICPC

Anxiety disorder/anxiety state

1.8

7.5

101

560

S06

ICPC

Rash localized

1.9

7.5

531

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

2.2

7.5

269

R5130, ,

SPAT

8.9

7.5

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

4.1

7.5

N76.0

ICD-10 Finland

Acute vaginitis

1.7

7.5

123

724

Z50.1

ICD-10 Finland

Other physical therapy

1.9

7.5

481

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.5

7.5

188

K56.7

ICD-10 Finland

Ileus, unspecified

3.0

7.5

108

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

7.5

240

1665

L84

ICPC

Back syndrome without radiat pain

1.9

7.5

504

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

7.5

138

841

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.3

7.5

251

WX200

NOMESCO Finland

Interscalenous plexus blockade

2.5

7.4

171

J01DA06

ATC

[U] cefuroxime

1.5

7.4

237

1643

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.2

7.4

258

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

7.4

1267

11400

ABD40

NOMESCO Finland

Implantation of spinal injection device

80.4

7.4

C10AC01

ATC

colestyramine; oral

2.4

7.4

214

GD1AD

NOMESCO Finland

Thorax CT examination

1.8

7.4

109

623

N06

ICPC

Sensation disturbance other

3.4

7.4

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

7.4

1254

11271

F44.7

ICD-10 Finland

Mixed dissociative [conversion] disorders

13.4

7.4

R06.2

ICD-10 Finland

Wheezing

1.9

7.4

449

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

7.4

421

3248

B01AA03

ATC

warfarin; systemic

1.5

7.4

255

1798

SPAT1167

SPAT

Insertion of urinary catheter

2.3

7.3

221

M01AX01

ATC

nabumetone; oral

2.1

7.3

326

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

6.8

7.3

J01MA01

ATC

ofloxacin; systemic

1.7

7.3

127

762

H02.4

ICD-10 Finland

Ptosis of eyelid

2.3

7.3

222

C08CA05

ATC

nifedipine; systemic

1.9

7.3

494

R03BB07

ATC

umeclidinium bromide; inhalant

4.2

7.3

G04BD08

ATC

solifenacin; oral

1.8

7.3

104

589

EAV, ,

NOMESCO Finland

2.7

7.3

138

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.1

7.3

320

SPAT1310

SPAT

Counselling related to known health issue

1.3

7.2

535

4293

I95.1

ICD-10 Finland

Orthostatic hypotension

2.2

7.2

287

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.0

7.2

368

M13.9

ICD-10 Finland

Arthritis, unspecified

1.7

7.2

132

802

F44.88

ICD-10 Finland

Other definite dissociation disorder

15.8

7.2

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.9

7.2

116

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.9

7.2

116

G35

ICD-10 Finland

Multiple sclerosis

2.7

7.2

133

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.6

7.2

154

975

X14

ICPC

Vaginal discharge

2.5

7.2

186

D07AC13

ATC

mometasone; topical

1.3

7.2

491

3893

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.7

7.2

141

873

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.7

7.2

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

3.7

7.2

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

2.5

7.2

174

R03BB01

ATC

ipratropium bromide; inhalant

2.2

7.2

275

K29.7

ICD-10 Finland

Gastritis, unspecified

2.1

7.2

295

S06.2

ICD-10 Finland

Diffuse brain injury

3.6

7.1

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.8

7.1

128

D07AA02

ATC

hydrocortisone; topical

1.5

7.1

246

1733

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

3.3

7.1

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

3.3

7.1

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.5

7.1

169

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.3

7.1

212

QXB99, ,

SPAT

2.2

7.1

244

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.7

7.1

140

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.0

7.1

406

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.5

7.1

197

1327

IGY02, ,

SPAT

2.6

7.1

146

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.3

7.0

238

G83.9

ICD-10 Finland

Paralytic syndrome, unspecified

10.1

7.0

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.3

7.0

232

U05

ICPC

Urination problems other

1.9

7.0

500

ZXE21

NOMESCO Finland

Procedure duration at least 3 but less than 4 hours

4.2

7.0

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.2

7.0

245

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.8

7.0

559

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.4

7.0

201

S16

ICPC

Bruise/contusion

2.3

7.0

239

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.7

7.0

116

687

W52

ICD-10 Finland

Crushed, pushed or stepped on by crowd or human stampede

2.8

7.0

124

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

3.3

7.0

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.6

7.0

143

896

SXC05

NOMESCO Finland

Other oral or dental procedure

1.7

7.0

125

756

R41.3

ICD-10 Finland

Other amnesia

2.3

7.0

214

N02AJ13

ATC

tramadol and paracetamol; systemic

2.4

7.0

183

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.4

7.0

183

KH1AD

NOMESCO Finland

CT of urinary organs

2.1

6.9

312

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

6.9

103

590

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

1.9

6.9

502

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

6.3

6.9

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.9

6.9

409

K27

ICPC

Fear cardiovascular disease other

3.7

6.9

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.7

6.9

112

659

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

4.0

6.9

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

4.0

6.9

K11.2

ICD-10 Finland

Sialoadenitis

2.2

6.9

273

X57

ICD-10 Finland

Unspecified privation

2.4

6.9

190

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.2

6.9

247

W10

ICD-10 Finland

Fall on and from stairs and steps

1.8

6.9

540

U71

ICPC

Cystitis/urinary infection other

1.7

6.9

116

690

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

3.6

6.9

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

3.1

6.9

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

6.9

126

767

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.8

6.9

100

570

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.9

6.9

103

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.8

6.9

504

A04AA01

ATC

ondansetron; systemic, rectal

1.7

6.9

136

845

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.2

6.9

241

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.0

6.8

348

R01AD12

ATC

fluticasone furoate; nasal

1.3

6.8

573

4675

F32.1

ICD-10 Finland

Moderate depressive episode

1.7

6.8

122

737

K80

ICPC

Cardiac arrhythmia NOS

1.6

6.8

141

885

G54.0

ICD-10 Finland

Brachial plexus disorders

2.2

6.8

248

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

3.8

6.8

F39

ICD-10 Finland

Unspecified mood [affective] disorder

2.6

6.8

149

NA1BG, ,

SPAT

2.5

6.8

173

K05.09

ICD-10 Finland

Acute gingivitis, UNS

2.7

6.8

126

R06.5

ICD-10 Finland

Mouth breathing

1.6

6.8

160

1038

A06AX04

ATC

linaclotide; oral

6.1

6.8

T51.0

ICD-10 Finland

Toxic effect: Ethanol

5.7

6.8

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

3.6

6.8

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.7

6.7

132

AN1

Coronary angiography

1.6

6.7

154

991

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.1

6.7

309

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.2

6.7

269

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.7

6.7

111

656

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.7

6.7

124

756

PA2AD

NOMESCO Finland

CT angiography of brain

3.5

6.7

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.7

6.7

115

687

X78

ICD-10 Finland

Intentional self-harm by sharp object

3.9

6.7

H81.4

ICD-10 Finland

Vertigo of central origin

3.9

6.7

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

6.7

330

X84

ICD-10 Finland

Intentional self-harm by unspecified means

7.2

6.7

F27

ICPC

Fear of eye disease

3.4

6.7

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

2.5

6.7

156

E000002, ,

ATC

1.5

6.7

184

1236

D07AD01

ATC

clobetasol; topical

1.4

6.7

272

1977

DQD34

NOMESCO Finland

Treatment of spasmodic dysfonia

22.6

6.7

SPAT1255

SPAT

Intravenous administration of medicine

1.7

6.7

106

620

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

6.7

231

NG1AD

NOMESCO Finland

Knee CT examination

2.7

6.7

133

G44.8

ICD-10 Finland

Other specified headache syndromes

2.7

6.7

133

N06AX05

ATC

trazodone; oral

2.3

6.7

212

R4190

NOMESCO Finland

Nutritional therapy

1.9

6.6

408

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.9

6.6

451

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.7

6.6

114

682

R20.1

ICD-10 Finland

Hypoaesthesia of skin

4.0

6.6

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

6.6

103

599

R44.1

ICD-10 Finland

Visual hallucinations

5.9

6.6

WX882

NOMESCO Finland

High dependency care

2.2

6.6

232

N05AB04

ATC

prochlorperazine; systemic, rectal

2.6

6.6

134

T82

ICPC

Obesity

1.9

6.6

417

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

4.2

6.5

F43.23

ICD-10 Finland

Adaptive disorder with other mental disorder

4.2

6.5

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.7

6.5

118

715

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

6.5

326

2455

K05.38

ICD-10 Finland

Other chronic periodontitis

2.2

6.5

246

QDB00

NOMESCO Finland

Suture of skin of lower limb

3.8

6.5

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

10.1

6.5

Z71.9

ICD-10 Finland

Counselling, unspecified

1.6

6.5

147

943

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

6.5

250

1797

IBA03

NOMESCO Finland

Psychotherapy evaluation

3.0

6.5

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.8

6.5

520

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.2

6.5

227

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.6

6.5

157

1025

N06AB08

ATC

fluvoxamine; oral

2.2

6.5

221

F41.3

ICD-10 Finland

Other mixed anxiety disorders

2.6

6.5

135

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

6.2

6.5

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.4

6.5

171

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

6.5

126

780

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

2.5

6.4

153

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

2.3

6.4

190

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.6

6.4

168

1116

A03FA02

ATC

cisapride; oral, rectal

1.7

6.4

111

665

I20.09

ICD-10 Finland

Unstable angina

1.8

6.4

478

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

3.4

6.4

D01AE15

ATC

terbinafine; topical

1.7

6.4

112

673

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

6.4

284

2096

A13

ICPC

Concern/fear medical treatment

2.4

6.4

178

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.0

6.4

357

A80

ICPC

Trauma/injury NOS

2.8

6.4

113

OAB93, ,

SPAT

1.6

6.4

128

798

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.2

6.4

242

JN4BD

NOMESCO Finland

Extensive body CT

1.6

6.4

156

1021

T74.1

ICD-10 Finland

Physical abuse

2.5

6.4

154

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.8

6.4

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.8

6.4

576

OAB74, ,

SPAT

3.1

6.4

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

6.6

6.3

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

6.6

6.3

U04

ICPC

Incontinence urine

1.8

6.3

532

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

2.9

6.3

K94

ICPC

Phlebitis/thrombophlebitis

2.9

6.3

C10AA07

ATC

rosuvastatin; oral

1.3

6.3

536

4373

NAG66

NOMESCO Finland

Posterior interbody fusion of lumbar spine, 2 vertebrae

3.6

6.3

R06AX26

ATC

fexofenadine; oral

1.7

6.3

124

769

R29

ICPC

Respiratory symptom/complaint other

1.7

6.3

124

769

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.6

6.3

131

I95.9

ICD-10 Finland

Hypotension, unspecified

2.6

6.3

131

N05AX15

ATC

cariprazine; oral

6.0

6.3

M96.0

ICD-10 Finland

Pseudarthrosis after fusion or arthrodesis

5.5

6.3

F50.9

ICD-10 Finland

Eating disorder, unspecified

3.2

6.3

J96.1

ICD-10 Finland

Chronic respiratory failure

2.6

6.3

137

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

11.1

6.3

S69.9

ICD-10 Finland

Unspecified injury of wrist and hand

2.5

6.3

161

SPAT1262

SPAT

Handing over of treatment supplies

1.4

6.3

266

1947

WX890

NOMESCO Finland

Intesive care monitoring

3.9

6.3

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.8

6.3

482

S63.3

ICD-10 Finland

Traumatic rupture of ligament of wrist and carpus

2.7

6.3

120

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.0

6.3

339

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.1

6.2

271

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.5

6.2

167

1116

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

7.0

6.2

ICC03

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric ward

7.0

6.2

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

6.2

187

1281

R31

ICD-10 Finland

Unspecified haematuria

1.6

6.2

155

1019

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.5

6.2

144

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.0

6.2

299

JAH01

NOMESCO Finland

Laparoscopy

1.9

6.2

433

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.0

6.2

306

NH1AD

NOMESCO Finland

Ankle and foot CT

2.3

6.2

200

B37.08

ICD-10 Finland

Other candidal stomatitis

4.0

6.2

L60.0

ICD-10 Finland

Ingrowing nail

1.8

6.2

514

H27

ICPC

Fear of ear disease

2.9

6.2

N05AL01

ATC

sulpiride; systemic

2.9

6.2

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

5.3

6.1

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

3.2

6.1

L72.1

ICD-10 Finland

Trichilemmal cyst

1.7

6.1

116

712

WX400

NOMESCO Finland

Inhalation anesthesy

1.9

6.1

405

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

3.3

6.1

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

2.0

6.1

293

Z31.5

ICD-10 Finland

Genetic counselling

1.7

6.1

575

N03AX23

ATC

brivaracetam; systemic

7.7

6.1

G40.10

ICD-10 Finland

Simple partial seizures

4.1

6.1

JAL21

NOMESCO Finland

Laparoscopic excision or destruction of lesion of peritoneum

3.0

6.1

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.0

6.1

308

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.1

6.1

274

R81

ICPC

Pneumonia

2.0

6.1

343

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

2.9

6.1

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

2.4

6.0

158

AA400

NOMESCO Finland

Electroconvulsive therapy

3.6

6.0

D07BC01

ATC

betamethasone and antiseptics; topical

1.5

6.0

188

1298

R06AX13

ATC

loratadine; oral

1.4

6.0

254

1858

Z11

ICPC

Compliance/being ill problem

3.5

6.0

S12

ICPC

Insect bite/sting

1.6

6.0

136

874

R68.88

ICD-10 Finland

Other specified general symptoms and signs, not elsewhere classified.

3.3

6.0

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

2.9

6.0

IGV01

NOMESCO Finland

Psychiatric network contact

2.9

6.0

F33.8

ICD-10 Finland

Other recurrent depressive disorders

3.4

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1135

5136

3.84

189.16

3.7

2.2

162.81

239.46

u/l

1.85

1093

4886

(3012095) Magnesium [Moles/volume] in Serum or Plasma

764

2896

3.67

161.72

3.1

3.7

0.82

mmol/l

0.01

720

2754

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1316

8371

2.71

93.94

8.5

7.6

1.21

mmol/l

0.05

1192

7267

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1219

7493

2.64

92.97

8.0

7.1

1.21

mmol/l

0.13

1154

6973

(3018418) pH of Serum or Plasma

896

4981

2.46

81.34

5.1

4.1

7.39

7.40

0.77

650

3580

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

741

3988

2.37

69.85

2.2

1.8

0.86

1.16

mg/l

3.06

595

3064

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1291

8994

2.26

62.61

7.6

6.6

10.36

11.72

umol/l

4.34

1250

8597

(3024561) Albumin [Mass/volume] in Serum or Plasma

1126

7488

2.17

60.56

5.3

5.2

36.20

35.97

g/l

0.67

1078

7062

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1110

7376

2.15

59.36

2.5

2.1

97.63

96.12

pmol/l

0.45

602

4020

(3013826) Glucose [Moles/volume] in Serum or Plasma

1389

10107

2.26

58.52

6.8

5.4

6.46

6.65

mmol/l

3.19

1339

9549

(3032080) INR in Blood by Coagulation assay

1110

7535

2.08

54.13

14.4

14.1

1.19

1.23

inr

1.70

933

6287

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

874

5462

2.08

53.09

3.8

2.6

59.85

74.54

u/l

0.49

821

5097

(3006315) Basophils [#/volume] in Blood

1267

9072

2.11

52.98

8.3

6.5

0.04

e9/l

0.76

1124

7847

(3001604) Monocytes [#/volume] in Blood

1265

9059

2.10

52.79

8.3

6.4

0.58

e9/l

0.46

1120

7834

(3021960) Folate [Moles/volume] in Serum or Plasma

787

4742

2.10

52.64

1.9

1.7

19.58

20.22

nmol/l

0.65

682

4067

(3003458) Phosphate [Moles/volume] in Serum or Plasma

472

2322

2.36

52.33

4.9

6.4

1.03

1.04

mmol/l

0.13

452

2162

(3019198) Lymphocytes [#/volume] in Blood

1282

9275

2.09

51.39

8.3

6.5

1.89

1.94

e9/l

0.82

1163

8225

(3013115) Eosinophils [#/volume] in Blood

1290

9358

2.09

51.28

8.5

6.7

0.20

0.19

e9/l

1.09

1166

8215

(3031040) Bacteria [#/volume] in Urine by Automated count

1472

11240

2.21

50.95

6.9

4.5

60.82

1713.05

e6/l

2.39

156

(3015377) Calcium [Moles/volume] in Serum or Plasma

910

5865

2.02

49.84

3.1

3.4

2.34

2.35

mmol/l

1.74

844

5397

(3013650) Neutrophils [#/volume] in Blood by Automated count

1352

10104

2.07

47.88

12.1

9.6

4.07

4.10

e9/l

0.21

1201

8811

(3019069) Monocytes/Leukocytes in Blood

1170

8321

2.00

47.48

8.2

6.7

8.77

8.74

0.15

1126

7836

(3002030) Lymphocytes/Leukocytes in Blood

1194

8553

2.00

47.45

8.1

6.6

28.13

28.14

0.01

1156

8150

(3022096) Basophils/Leukocytes in Blood

1166

8302

1.99

46.93

8.2

6.7

0.67

0.68

0.36

1122

7806

(3033658) Prothrombin time (PT) actual/Normal

730

4421

2.03

46.88

6.0

4.3

91.92

90.73

0.62

715

4323

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1593

12720

2.30

46.88

5.6

4.3

10.12

11.30

mm/h

3.56

1524

11957

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1621

13044

2.35

46.73

10.6

8.1

76.83

78.72

u/l

0.91

1570

12436

(3006504) Eosinophils/Leukocytes in Blood

1164

8313

1.97

46.08

8.2

6.6

2.91

2.83

0.67

1122

7825

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

574

3203

2.12

45.85

5.5

3.7

93.53

456.34

ng/l

6.95

403

2360

(3014111) Lactate [Moles/volume] in Serum or Plasma

349

1594

2.44

45.12

6.5

9.2

1.33

mmol/l

0.01

341

1563

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

940

6285

1.95

44.78

5.2

3.6

26.36

72.32

ng/l

1.96

648

4212

(42870588) Differential panel, method unspecified - Blood

899

5924

1.95

44.70

7.5

6.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

106

6.81

44.33

1.3

1.5

5.28

8.04

u/l

1.00

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

292

1236

2.60

44.31

2.5

2.4

18.84

21.78

au/ml

0.26

141

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

410

2026

2.29

44.20

3.2

3.0

6.72

7.84

umol/l

0.53

342

1789

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

182

603

3.22

43.37

2.1

2.3

184.64

447.41

ug/l

1.88

172

575

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

909

6065

1.92

43.04

3.9

3.3

33.50

31.91

u/l

0.47

866

5750

(3002582) Erythrocytes [#/volume] in Urine

857

5615

1.93

42.81

4.8

3.3

30.56

82.44

e6/l

2.36

693

4262

(3018010) Neutrophils/Leukocytes in Blood

1157

8404

1.91

41.74

8.1

6.5

56.87

57.06

0.23

1127

8060

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

512

2822

2.10

41.67

2.4

1.9

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

256

1068

2.60

39.82

4.6

4.5

24.38

24.17

mmol/l

0.54

250

1054

(3018677) aPTT in Platelet poor plasma by Coagulation assay

484

2654

2.09

39.68

2.7

2.3

29.68

29.58

0.13

474

2575

(3012544) pH of Venous blood

360

1761

2.28

39.36

4.7

4.2

7.37

7.38

1.28

205

1031

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

266

1139

2.54

39.17

1.3

24.51

47.57

au/ml

1.40

(3002032) Base excess in Venous blood by calculation

349

1704

2.27

38.25

4.7

4.2

1.70

1.79

mmol/l

0.18

312

1456

(3019309) Folate [Moles/volume] in Red Blood Cells

475

2636

2.06

37.43

1.8

1.7

1160.56

1167.56

nmol/l

0.06

376

2021

(3021447) Carbon dioxide [Partial pressure] in Venous blood

355

1761

2.24

37.37

4.9

4.2

5.88

5.84

kpa

0.36

345

1708

(3018095) Leukocytes [#/volume] in Urine

937

6510

1.84

37.35

5.7

3.9

36.39

99.42

e6/l

4.22

707

4519

(3030467) Casts [#/volume] in Urine by Automated count

749

4856

1.87

37.28

4.7

3.2

0.34

0.39

e6/l

0.30

584

3524

(3000991) Gas panel - Venous blood

324

1565

2.28

36.29

7.9

10.5

—

(3023368) Bacteria identified in Blood by Culture

718

4628

1.87

36.14

5.2

4.4

—

(3019977) pH of Arterial blood

377

1944

2.16

35.92

6.4

9.6

7.42

7.41

0.40

197

1058

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

378

1952

2.16

35.87

6.4

9.5

5.08

5.11

kpa

0.23

360

1876

(3000850) Epithelial cells [#/volume] in Urine

627

3877

1.90

35.87

3.4

2.7

5.17

6.00

e6/l

1.02

589

3529

(3027801) Oxygen [Partial pressure] in Arterial blood

378

1953

2.16

35.82

6.4

9.5

11.90

12.43

kpa

1.44

359

1880

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1169

8785

1.81

35.03

3.8

3.1

121.98

115.28

ug/l

0.35

1105

8274

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

712

4616

1.85

34.90

2.8

2.3

2.75

2.77

mg/l

0.08

607

3989

(3003396) Base excess in Arterial blood by calculation

372

1932

2.14

34.69

6.4

9.6

0.44

0.88

mmol/l

1.32

315

1582

(3020630) Protein [Mass/volume] in Serum or Plasma

287

1346

2.32

34.35

2.8

66.55

66.63

g/l

0.07

266

1257

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

396

2116

2.09

34.23

2.4

1.8

—

(3015736) pH of Urine

1024

7455

1.78

33.63

4.1

3.4

6.34

6.21

3.36

586

4251

(3022948) Iron [Moles/volume] in Serum or Plasma

499

2913

1.95

33.58

2.8

2.6

13.09

13.48

umol/l

0.65

469

2717

(3036481) Cortisol [Moles/volume] in Serum or Plasma

344

1755

2.16

33.49

2.2

356.82

379.52

nmol/l

1.29

325

1643

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1069

7920

1.76

32.66

3.0

2.5

75.87

76.07

nmol/l

0.08

999

7261

(3037522) Nuclear Ab [Titer] in Serum

450

2560

1.98

32.52

1.4

498.72

490.19

titre

0.04

538

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

376

2017

2.07

31.96

2.4

1.8

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

334

1715

2.14

31.86

3.6

2.5

32.82

68.28

u/l

0.68

284

1446

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

505

3017

1.91

31.42

4.1

2.9

0.83

1.00

e6/l

0.69

286

1570

(3004789) Transferrin [Mass/volume] in Serum or Plasma

465

2707

1.94

31.26

2.8

2.6

2.35

2.33

g/l

0.39

433

2515

(40758558) Short blood count panel - Blood

775

5297

1.76

30.90

7.8

6.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

550

3395

1.86

30.81

1.4

1.3

22.56

28.99

iu/ml

0.42

150

1033

(3026782) Osmolality of Urine

538

3301

1.87

30.70

3.5

2.9

521.36

534.18

mosm/kgh2o

0.69

491

2894

(3028707) Methadone [Presence] in Urine by Screen method

122

390

3.27

30.69

3.6

2.8

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

702

4691

1.77

30.07

3.2

1006.34

1251.19

ng/l

1.08

600

3994

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1593

13484

1.94

29.16

5.6

4.4

14.59

14.67

pmol/l

0.60

1510

12504

(3009466) Valproate [Moles/volume] in Serum or Plasma

267

3.69

29.16

6.6

6.0

373.55

357.69

umol/l

0.46

238

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

663

4400

1.76

28.82

1.4

1.3

1.20

1.47

u/ml

0.33

172

1221

(3024354) Oxygen [Partial pressure] in Venous blood

294

1492

2.14

28.72

4.3

3.6

4.57

4.60

kpa

0.10

283

1446

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

227

1038

2.34

28.57

6.9

12.0

24.22

24.28

mmol/l

0.11

218

1019

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

466

2788

1.88

28.49

4.3

3.1

4.43

2.34

e6/l

2.28

238

1337

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

138

497

2.91

28.27

1.5

1.4

782.24

530.41

mg/l

0.53

131

473

(3035350) Ketones [Presence] in Urine by Test strip

1191

9316

1.70

27.95

4.8

3.8

13.89

5.09

estimate

0.42

227

1982

(3026008) Bacteria identified in Urine by Culture

728

5017

1.71

27.33

4.1

3.0

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

125

435

3.00

27.22

1.5

12.77

34.81

e6/l

0.75

322

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

122

4.95

27.02

1.1

4.91

3.07

nmol/l

—

(3021601) Nitrite [Presence] in Urine by Test strip

1176

9216

1.68

26.94

4.7

3.8

0.00

estimate

0.80

218

1959

(3009261) Glucose [Presence] in Urine by Test strip

1190

9363

1.68

26.77

4.8

3.8

0.00

0.17

estimate

0.54

215

1849

(3044290) Cell count panel - Cerebral spinal fluid

119

407

3.05

26.71

1.6

1.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

125

441

2.96

26.57

1.6

1.5

396.94

1585.98

e6/l

0.87

103

338

(3004588) Protein electrophoresis panel - Serum or Plasma

228

1082

2.25

26.22

2.8

2.4

—

(3016502) Oxygen saturation in Arterial blood

319

1740

1.99

25.43

6.7

10.1

95.10

95.69

0.70

312

1683

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

253

1273

2.13

25.09

3.9

4.3

86.68

87.31

ng/l

0.03

217

1140

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1862

16953

2.70

24.83

26.7

15.2

20.98

23.44

mg/l

3.11

1647

13911

(3021589) Normoblasts [#/volume] in Blood

1027

7872

1.63

24.77

13.7

11.2

0.00

e9/l

0.04

834

6465

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

400

2375

1.86

24.65

2.5

1.8

1.61

1.47

1.89

359

2103

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

413

2481

1.84

24.50

3.0

2.6

22.52

23.30

0.61

393

2320

(40768797) Stomach Pathology biopsy report

401

2392

1.85

24.31

1.3

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

141

556

2.65

24.29

2.8

2.5

0.96

1.06

g/l

0.12

125

492

(3007164) IgA [Mass/volume] in Serum or Plasma

579

3855

1.71

24.02

1.8

1.5

2.27

2.37

g/l

0.62

347

2463

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

243

1228

2.12

23.78

1.8

1.7

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

148

605

2.56

23.70

2.7

2.4

2.74

2.92

g/l

1.63

136

561

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

149

4.26

23.63

1.1

1.2

38.65

39.02

mg/l

0.03

121

(3023183) Ammonium ion [Moles/volume] in Plasma

111

392

2.94

23.54

4.0

3.2

30.66

34.67

umol/l

1.27

103

355

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

210

1007

2.21

23.46

2.3

1.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1768

15822

2.12

23.32

7.2

5.3

1.74

1.87

mu/l

5.48

1704

14803

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

120

445

2.81

23.27

1.5

1.3

3.69

3.76

mmol/l

0.45

112

424

(3044640) Blood type and Crossmatch panel - Blood

785

5691

1.63

23.26

3.0

2.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

152

638

2.50

23.02

2.6

2.3

7.07

7.33

g/l

1.22

140

594

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

152

638

2.50

23.02

2.6

2.3

3.52

3.77

g/l

1.52

140

594

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

152

638

2.50

23.02

2.6

2.3

4.23

4.22

g/l

0.07

140

593

(3019550) Sodium [Moles/volume] in Serum or Plasma

1861

17030

2.59

22.87

29.2

17.6

139.43

139.65

mmol/l

3.13

1850

16709

(3023103) Potassium [Moles/volume] in Serum or Plasma

1863

17065

2.60

22.70

29.4

17.7

3.95

3.96

mmol/l

0.70

1849

16721

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

505

3284

1.72

22.61

2.8

2.43

2.44

mmol/l

2.29

453

2963

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1443

12194

1.68

22.36

5.2

3.4

53.95

46.45

u/l

2.31

1385

11604

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

188

885

2.24

21.94

1.7

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

135

548

2.57

21.92

2.8

2.4

9.74

10.49

g/l

1.31

123

503

(3048689) Calprotectin [Mass/mass] in Stool

398

2456

1.78

21.28

2.4

2.6

121.62

117.36

ug/g

0.09

321

1964

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

190

3.67

21.08

1.1

—

(4198724) Urine methamphetamine measurement

5.21

21.02

3.3

2.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1045

8237

1.57

20.98

3.4

2.8

—

estimate

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

122

483

2.63

20.84

2.7

2.4

0.02

g/l

0.12

112

442

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

218

1113

2.08

20.66

3.2

3.6

4.41

4.55

pmol/l

1.37

198

999

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

215

1100

2.07

20.25

7.8

12.0

0.66

0.64

0.20

210

1092

(3020779) Urea [Moles/volume] in Serum or Plasma

278

1560

1.91

20.11

6.3

8.2

8.63

9.17

mmol/l

0.64

267

1505

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

113

439

2.67

20.04

2.8

2.4

0.00

g/l

-0.00

105

417

(1001926) Buprenorphine [Presence] in Urine by Screen method

157

712

2.31

19.99

3.4

2.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

472

3120

1.67

19.48

1.5

1.3

2.98

10.43

u/ml

6.74

178

1231

(3005719) IgG [Mass/volume] in Serum or Plasma

263

1465

1.92

19.42

3.1

2.8

9.88

10.62

g/l

2.55

242

1360

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

143

3.93

18.90

1.0

1.1

—

(3019150) Specific gravity of Urine by Refractometry

585

4112

1.60

18.76

4.6

3.8

1.02

1.39

kg/l

0.50

415

2719

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

116

472

2.55

18.74

2.7

2.4

0.01

0.00

g/l

0.71

105

418

(3005322) IgE [Units/volume] in Serum or Plasma

238

1305

1.94

18.38

1.4

1.3

194.79

215.28

u/ml

0.18

226

1212

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

215

1142

1.99

18.21

7.6

11.6

1.23

1.31

0.67

210

1134

(3025941) Bacteria identified in Stool by Culture

186

939

2.08

18.11

1.3

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

190

969

2.06

18.00

8.3

13.0

16.32

16.06

0.55

184

932

(3052851) Hemolysis interference index of Serum or Plasma

112

457

2.54

17.99

3.2

3.1

1.74

1.92

index

0.14

247

(3011288) Drugs identified in Urine by Screen method Nominal

143

653

2.28

17.90

4.6

2.7

—

(3016879) Cocaine [Presence] in Urine

170

837

2.13

17.67

3.7

2.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

602

4323

1.56

17.35

3.2

2.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

5.39

17.33

3.1

3.0

26.81

30.27

umol/l

0.91

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

4.77

17.31

3.2

3.1

197.71

118.19

umol/l

0.90

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

181

920

2.06

17.29

3.4

3.2

1.44

1.27

0.95

181

914

(4027681) Cerebrospinal fluid IgG ratio and IgG index

117

4.09

17.15

1.1

1.2

0.64

0.56

ratio

0.66

(3023410) Appearance of Cerebral spinal fluid

215

3.19

16.80

1.8

1.6

—

(3014051) Protein [Presence] in Urine by Test strip

679

5052

1.52

16.48

3.3

2.9

0.00

0.02

—

(3000764) Benzodiazepines [Presence] in Urine

175

903

2.03

16.03

3.6

2.1

—

(3016018) Differential panel - Cerebral spinal fluid

217

3.11

15.90

1.9

1.5

—

(36660697) Celiac disease serology panel - Serum

258

1526

1.79

15.60

1.3

1.2

—

(3028300) Cannabinoids [Presence] in Urine

175

912

2.01

15.59

3.7

2.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

496

3480

1.57

15.55

1.8

1.7

13667885.14

30285946.84

pmol/l

0.52

439

2942

(3027008) Opiates [Presence] in Urine

174

907

2.01

15.49

3.7

2.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

117

522

2.32

15.47

1.6

1.4

272.31

278.91

ug/g

0.12

302

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

111

484

2.37

15.46

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

611

4504

1.52

15.23

3.0

2.7

333.51

339.85

umol/l

0.73

528

4014

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

110

481

2.36

15.23

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

229

1320

1.83

15.05

3.0

2.4

4.96

7.09

ug/l

1.25

193

1194

(3014765) Yersinia sp identified in Stool by Organism specific culture

109

478

2.36

14.99

1.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

186

1008

1.93

14.80

3.8

4.5

1.74

1.65

mmol/l

0.12

133

758

(3027944) Amphetamines [Presence] in Urine

170

898

1.98

14.57

3.7

2.0

—

(42529406) Shigella sp [Presence] in Stool by Culture

109

486

2.32

14.44

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

105

3.97

14.43

1.1

1.3

138.85

142.28

nmol/l

0.22

105

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

207

1174

1.85

14.31

4.2

4.5

5.19

5.14

kpa

0.40

201

1137

(44816559) Phosphatidylethanol [Mass/volume] in Blood

165

870

1.98

14.21

1.9

1.7

0.26

0.32

mg/l

0.84

421

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

203

1151

1.85

14.04

2.9

3.0

163.51

188.28

ng/l

0.42

177

1052

(3042936) Bacteria identified in Isolate by Culture

375

2521

1.60

13.94

2.4

2.1

—

(3009343) pH of Capillary blood

202

1147

1.85

13.91

4.2

4.5

7.41

7.42

0.46

177

968

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

4.63

13.78

1.9

1.3

161.01

122.10

nmol/l

0.45

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

130

637

2.11

13.68

1.4

1.2

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1752

16162

1.74

13.60

23.4

14.4

85.58

84.43

ml/min/173m2

1.37

1664

14881

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

268

1665

1.71

13.55

3.1

2.4

0.23

0.22

g/l

1.82

256

1554

(3013139) Helicobacter pylori Ag [Presence] in Stool

203

1169

1.82

13.35

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

174

956

1.90

13.27

1.1

—

0.89

—

(3024928) Oxygen saturation in Venous blood

103

471

2.25

12.88

3.0

3.5

63.28

61.53

0.33

455

(40768804) Tissue Pathology biopsy report

851

6859

1.42

12.79

2.4

2.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1331

11634

1.44

12.55

4.1

3.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

226

2.80

12.50

1.6

26.58

30.60

ng/l

0.19

226

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

117

3.56

12.41

1.0

1.1

0.99

1.08

u/l

0.56

(3027945) Reticulocytes/Erythrocytes in Blood

294

1914

1.63

12.37

3.0

2.9

1.78

1.79

0.02

259

1729

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

3.94

12.28

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

153

3.19

12.23

1.2

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1741

16120

1.67

12.22

5.8

4.8

5.93

5.89

mmol/l

0.77

1647

14956

(3003181) Sodium [Moles/volume] in Urine

294

2.54

12.12

1.6

1.4

61.35

64.07

mmol/l

0.24

246

(3023511) Choriogonadotropin [Units/volume] in Urine

444

2.25

12.11

1.6

1.3

—

(3036489) Thrombin time

136

709

1.99

12.10

2.6

2.5

20.02

20.99

1.73

120

635

(3009508) Creatinine [Moles/volume] in Urine

744

5905

1.42

11.97

4.0

3.5

7.72

7.87

mmol/l

0.35

652

5080

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

296

1947

1.61

11.92

3.6

4.3

228.59

244.12

u/l

1.36

280

1856

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

178

2.97

11.76

1.2

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

147

795

1.92

11.76

1.7

344.67

295.81

mu/l

0.77

137

721

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

158

3.09

11.61

1.2

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

863

7054

1.40

11.59

4.7

3.6

0.03

estimate

0.13

183

1630

(3028026) IgM [Mass/volume] in Serum or Plasma

195

1159

1.76

11.50

2.3

1.8

1.55

1.36

g/l

0.28

177

1077

(3028192) IgG subclass 2 [Mass/volume] in Serum

189

2.85

11.16

1.4

1.3

2.65

2.99

g/l

0.80

138

(3024139) IgG subclass 3 [Mass/volume] in Serum

189

2.85

11.16

1.4

1.3

0.38

0.40

g/l

0.17

137

(3027135) IgG subclass 1 [Mass/volume] in Serum

189

2.85

11.16

1.4

1.3

5.88

6.91

g/l

1.66

139

(3015171) Extractable nuclear Ab [Units/volume] in Serum

134

720

1.92

10.93

1.2

0.26

1.09

u/ml

1.01

(3000494) Fungus identified in Specimen by Culture

318

2182

1.55

10.60

1.6

1.5

—

(4062490) Immunoglobulin typing, IgG

190

2.78

10.48

1.4

1.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

112

577

2.00

10.33

1.8

1.7

1.21

1.19

g/l

0.23

105

544

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1882

17947

2.02

10.32

31.5

19.1

76.78

76.27

umol/l

0.23

1873

17767

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

331

2.32

10.24

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

331

2.32

10.24

1.5

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

489

3683

1.44

10.22

2.0

1.6

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

150

2.98

10.06

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

150

2.98

10.06

1.2

1.1

—

(3022145) Colonoscopy Study observation

293

2002

1.54

9.92

1.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1696

15765

1.53

9.86

7.1

6.0

38.92

38.88

mmol/mol

0.06

1623

14889

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

147

2.97

9.79

1.2

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

123

670

1.89

9.65

1.3

1.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

108

563

1.97

9.65

1.8

1.7

0.24

g/l

0.02

533

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1579

14488

1.45

9.62

31.2

18.5

13.64

13.54

2.24

1568

14303

(3018333) Ribosomal P Ab [Presence] in Serum

144

2.96

9.52

1.2

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

113

603

1.93

9.43

2.8

24.95

24.75

mmol/l

0.18

108

595

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

203

1287

1.64

9.42

1.6

1.5

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

146

2.92

9.30

1.2

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

512

1.98

9.06

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

120

663

1.86

9.02

1.7

—

(3023420) DNA double strand Ab [Units/volume] in Serum

134

767

1.80

8.99

1.8

1.9

11.26

7.66

iu/ml

0.39

184

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

137

790

1.79

8.97

2.3

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

113

615

1.89

8.90

2.8

1.9

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

320

2.23

8.84

1.8

1.7

0.83

0.80

g/l

0.07

257

(3030981) Hyaline casts [#/volume] in Urine by Automated count

213

1389

1.60

8.81

2.7

2.4

0.29

0.46

e6/l

0.90

199

1324

(3020191) Ethanol [Moles/volume] in Serum or Plasma

152

2.80

8.67

2.7

1.4

1.46

1.18

promille

0.44

122

(3009214) Lutropin [Units/volume] in Serum or Plasma

114

628

1.87

8.66

1.4

9.97

8.49

u/l

0.71

101

505

(40760892) CBC W Ordered Manual Differential panel - Blood

534

4186

1.38

8.64

5.4

4.6

—

(3029937) Albumin [Presence] in Urine by Test strip

633

5100

1.35

8.60

5.2

3.9

0.00

estimate

1.54

212

1825

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

103

551

1.92

8.56

3.0

188.98

184.60

0.18

528

(3004716) Salmonella sp identified in Stool by Organism specific culture

155

941

1.70

8.48

1.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

4.48

8.37

2.3

2.2

14.60

17.16

umol/l

0.48

(3016650) Hepatitis A virus Ab [Presence] in Serum

329

2.17

8.28

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

105

573

1.88

8.22

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

325

2358

1.45

8.13

1.7

1.6

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

142

852

1.72

8.12

3.3

2.3

3012.81

5860.41

u/l

0.80

348

(3021879) Hepatitis B virus core Ab [Presence] in Serum

229

1549

1.54

8.07

1.6

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

136

2.83

8.03

2.5

2.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

133

789

1.74

7.92

1.6

2.0

38.77

39.02

u/l

0.05

119

710

(3023323) Follitropin [Units/volume] in Serum or Plasma

162

1016

1.65

7.85

1.5

1.4

25.30

25.79

iu/l

0.07

146

860

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

330

2.13

7.83

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

197

2.47

7.76

1.6

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

133

2.82

7.76

1.8

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

101

3.10

7.71

1.2

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

5.93

7.68

1.1

1.0

—

(1616796) Gas panel - Central venous blood

369

2.04

7.54

3.6

3.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1861

17857

1.72

7.48

16.9

11.7

27.70

26.53

u/l

1.34

1836

17417

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

461

1.93

7.47

4.1

3.5

6.90

4.13

ratio

0.31

259

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

115

667

1.77

7.42

1.7

38.12

13.22

u/ml

0.39

159

(3012501) Base excess in Blood by calculation

333

2.08

7.28

3.5

4.1

2.71

2.41

mmol/l

0.24

218

(3047181) Lactate [Moles/volume] in Blood

487

1.89

7.27

5.1

7.9

1.39

1.29

mmol/l

0.46

422

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

101

567

1.82

7.27

2.1

1.8

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

205

2.37

7.15

1.3

0.17

0.26

nmol/l

0.56

164

(3023520) Reticulocytes [#/volume] in Blood

212

1448

1.52

7.13

2.4

2.8

72.62

71.22

e9/l

0.20

151

1052

(3042517) Benzodiazepines panel - Urine

7.95

7.10

1.9

2.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

501

3997

1.34

7.02

2.2

2.0

—

(3017732) Neutrophils [#/volume] in Blood

305

2247

1.42

6.97

3.8

3.2

4.07

4.85

e9/l

1.72

273

1987

(3045414) Leukocytes [Presence] in Urine

231

1616

1.49

6.93

2.2

2.1

0.04

0.01

estimate

0.28

351

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

107

625

1.75

6.76

2.2

1.9

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

519

1.81

6.54

4.4

3.6

52.72

60.02

mg/l

0.17

443

(4024509) Urine culture

126

779

1.66

6.48

2.1

1.9

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

521

1.80

6.47

4.4

3.6

51.60

48.83

mg/l

0.05

446

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

248

2.17

6.41

1.3

1.4

0.44

0.39

nmol/l

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

222

2.24

6.41

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

122

751

1.67

6.39

1.9

1.46

1.51

g/l

0.23

103

662

(40768443) Skin Pathology biopsy report

119

728

1.68

6.38

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

195

1341

1.50

6.36

1.3

1.2

173.90

147.79

u/ml

0.30

516

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

152

991

1.58

6.31

1.1

—

(3022313) Gas panel - Capillary blood

131

824

1.63

6.31

4.7

4.9

—

(3035933) Granulocytes/Leukocytes in Blood

416

1.89

6.29

3.0

3.2

58.59

57.97

0.19

416

(3011985) Renin [Units/volume] in Plasma

224

2.22

6.28

1.6

1.4

84.71

70.37

mu/l

0.09

206

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

103

2.84

6.27

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

446

1.85

6.24

1.3

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

508

1.79

6.11

1.2

1.1

4.86

3.88

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

4.13

6.09

1.1

1.2

62.50

79.38

—

(3023419) Bacteria identified in Sputum by Culture

234

2.17

6.06

4.9

2.7

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

2.90

6.05

1.2

1.4

—

73.73

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

220

1566

1.46

6.04

2.0

2.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

10.05

6.03

1.0

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

409

1.87

5.97

1.4

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

4.02

5.90

1.1

1.3

74.33

88.33

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

484

1.79

5.89

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

148

2.46

5.87

3.0

1.9

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.31

5.86

1.7

2.5

0.60

0.62

mmol/l

0.56

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

376

1.89

5.84

1.5

1.6

—

(3008295) Osmolality of Serum or Plasma

205

2.22

5.84

1.4

1.6

275.71

281.11

mosm/kgh2o

0.86

155

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

212

2.20

5.81

1.3

1.4

—

nmol/l

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

131

2.54

5.79

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.88

5.78

1.5

1.8

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

328

1.95

5.77

1.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

518

1.75

5.74

1.3

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

187

1304

1.48

5.71

1.9

2.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

303

1.98

5.62

1.2

1.1

15.21

133.01

iu/ml

1.87

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

416

3330

1.32

5.55

1.8

1.7

—

(1761868) Lipid panel - Serum or Plasma

605

7085

0.79

5.41

3.3

3.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

3.11

5.34

1.3

1.2

0.32

0.29

g/l

0.68

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

316

1.93

5.34

1.3

1.2

182.86

301.90

titre

—

(3000060) B lymphocytes [#/volume] in Blood

3.20

5.32

1.6

2.1

0.21

0.26

e9/l

0.34

(3051611) Lipemic interference index of Serum or Plasma

150

2.36

5.25

3.3

13.17

12.16

index

0.29

(3006184) Hemoglobin [Mass/volume] in Capillary blood

399

1.81

5.18

1.8

2.3

134.05

130.12

g/l

0.65

320

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.24

5.17

1.1

83.11

90.56

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

604

1.66

5.16

2.9

2.8

95.92

92.84

0.64

585

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

512

1.71

5.15

3.2

3.6

0.39

0.36

iu/ml

0.21

268

(3006922) Hepatitis E virus Ab [Presence] in Serum

139

2.40

5.15

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

342

1.87

5.13

1.4

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.02

5.10

1.2

1.3

—

(3049717) Cytology report of Urine Cyto stain

599

1.65

5.07

2.5

2.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

220

1618

1.40

5.05

2.8

2.4

12.34

13.06

nmol/l

0.65

203

1477

(3010838) Calcium [Moles/time] in 24 hour Urine

301

1.92

5.05

2.1

2.0

6.89

5.14

mmol/24h

0.53

270

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

172

2.23

5.05

1.1

1.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

3.19

5.04

1.1

1.5

80.88

90.52

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

231

1720

1.39

4.94

4.2

3.3

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

105

667

1.61

4.92

2.1

1.9

46.58

39.46

nmol/l

1.53

105

645

(3006442) Creatine [Moles/volume] in Serum or Plasma

124

2.44

4.89

2.0

1.4

71.90

78.37

umol/l

0.76

124

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

437

1.74

4.86

1.2

7.85

51.41

u/ml

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

820

7220

1.23

4.83

2.2

1.9

1.41

1.37

mmol/l

0.84

716

6177

(3002256) Pathology report gross observation

297

2309

1.34

4.82

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

285

1.92

4.80

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.18

4.76

1.1

1.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

138

2.34

4.76

1.1

10.60

7.67

iu/ml

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

110

714

1.57

4.72

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

273

1.93

4.71

1.1

4.51

2.19

—

(3000475) Leukocytes [#/volume] in Synovial fluid

427

1.74

4.68

1.5

1.6

17226.24

11286.25

e6/l

0.48

305

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

511

1.67

4.67

1.8

2.1

2.38

4.17

iu/l

2.57

215

(21494815) CD4 cells/Lymphocytes in Specimen

165

2.20

4.66

2.6

2.2

44.94

39.94

1.33

165

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

7.17

4.65

1.0

1.4

5.00

14.21

u/l

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

468

1.69

4.58

1.4

1.6

—

(3022621) pH of Urine by Test strip

190

1387

1.41

4.57

2.6

2.4

6.09

6.12

0.19

139

922

(3020123) Porphyrins [Interpretation] in Serum or Plasma

8.21

4.56

1.1

1.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

601

5145

1.24

4.54

4.2

3.2

0.11

0.04

estimate

0.28

188

1570

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

619

1.60

4.48

1.5

1.6

0.06

12.50

iu/ml

0.51

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

185

1349

1.41

4.48

2.9

2.7

75.90

69.10

ml/min/173m2

1.42

567

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

526

1.64

4.45

1.2

4.10

2.35

u/ml

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

5.82

4.44

1.2

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

305

2409

1.31

4.43

2.3

2.1

—

(21494755) Public health laboratory ask at order entry panel

128

1835

0.68

4.41

1.3

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

538

1.63

4.32

1.2

110.91

94.41

titre

0.19

(3051651) Icteric interference index of Serum or Plasma

2.55

4.30

3.3

3.7

0.54

0.86

index

1.25

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

212

2.00

4.28

1.4

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

11.70

4.27

1.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

2.71

4.25

2.5

2.2

128.29

147.27

nmol/l

0.51

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.05

4.24

1.3

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

108

2.43

4.22

1.4

2.1

—

(3019225) pH of Specimen

203

1519

1.37

4.22

4.7

4.2

7.37

7.36

1.35

153

1128

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

4.82

4.18

1.1

1.0

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

488

1.64

4.18

2.0

1.7

—

(3035715) Granulocytes [#/volume] in Blood

329

1.79

4.17

3.5

3.3

4.11

4.20

e9/l

0.13

329

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

397

1.71

4.14

1.3

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

208

1.99

4.13

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

482

1.64

4.13

1.7

2.2

13.13

11.46

mg/l

1.13

451

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

180

1327

1.39

4.10

3.9

3.6

1.22

1.23

mmol/l

1.75

157

1143

(3021440) Promyelocytes/Leukocytes in Blood

202

1518

1.37

4.10

4.5

0.12

0.10

0.11

405

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

530

1.61

4.09

1.2

2.67

8.81

u/ml

—

(3017181) Myelocytes/Leukocytes in Blood

209

1581

1.36

4.07

4.5

0.94

0.99

0.11

468

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

155

2.15

4.06

1.7

1.3

0.48

2.09

u/ml

0.81

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

8.03

4.06

1.0

1.3

595.63

566.90

u/l

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.21

4.06

1.3

1.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.68

3.99

1.0

1.2

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

190

2.02

3.99

1.2

—

28.80

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

349

1.74

3.97

1.4

—

(3012516) Albumin [Mass/volume] in Urine

615

5342

1.22

3.94

3.9

3.5

34.86

49.92

mg/l

1.50

430

3504

(3020682) Albumin/Creatinine [Ratio] in Urine

625

5438

1.22

3.94

4.6

4.2

6.06

9.01

mg/mmol

1.46

417

3459

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

325

2630

1.28

3.92

2.4

2.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

158

2134

0.72

3.89

2.1

1.9

3.51

3.50

ratio

0.02

122

1637

(3007461) Platelets [#/volume] in Blood

1898

18555

1.58

3.87

39.1

23.0

252.01

252.53

e9/l

0.13

1885

18230

(3026361) Erythrocytes [#/volume] in Blood

1898

18565

1.57

3.74

39.0

23.0

4.48

4.52

e12/l

2.85

1883

18197

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

1898

18565

1.57

3.74

39.7

23.5

40.29

40.78

1.13

1893

18391

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

584

1.55

3.70

3.1

2.8

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

253

1.84

3.68

1.8

1.6

365.43

330.55

mu/l

0.31

211

(3010813) Leukocytes [#/volume] in Blood

1898

18569

1.56

3.68

39.1

23.0

6.83

6.73

e9/l

1.45

1882

18192

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

135

2.17

3.68

1.1

1.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

1898

18572

1.56

3.64

39.3

23.1

134.89

135.84

g/l

2.20

1893

18407

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1656

15876

1.27

3.64

4.6

4.1

1.37

1.29

mmol/l

3.86

1573

14795

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

321

1.73

3.63

2.1

3.0

6.42

8.19

pmol/l

1.78

321

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

136

2.15

3.61

1.1

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

212

1.91

3.59

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

5.31

3.51

1.2

1.8

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

482

1.58

3.44

1.5

1.6

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

100

2.32

3.43

5.0

7.7

7.16

199.49

ug/l

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

100

2.32

3.43

1.3

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

5.02

3.37

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

147

2.06

3.37

1.2

1.1

26.76

16.40

u/ml

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

203

1.89

3.35

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

203

1.89

3.35

1.4

—

(3025159) Blasts/Leukocytes in Blood

199

1541

1.32

3.34

4.7

4.8

0.12

0.02

374

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

269

1.77

3.34

1.7

1.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

204

1.88

3.31

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.44

3.31

1.0

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.55

3.29

2.8

2.4

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

256

1.78

3.27

1.1

1.2

—

15.00

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

489

1.55

3.25

1.1

10.70

5.77

eliau/ml

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

116

1595

0.71

3.20

1.8

1.7

3.54

3.48

mmol/l

0.16

1106

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

151

2.00

3.15

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

151

2.00

3.15

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

151

2.00

3.15

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

290

1.71

3.12

2.6

2.7

4.89

6.41

umol/l

0.70

213

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.68

3.08

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

188

1.88

3.06

6.7

6.4

6.87

7.21

mmol/l

0.25

162

(21494814) CD8 cells/Lymphocytes in Specimen

2.51

3.04

3.5

1.8

30.71

28.28

0.33

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

300

1.68

3.04

1.2

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

228

1823

1.28

3.03

7.8

6.7

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

3.56

2.99

1.4

1.3

1.18

mmol/l

0.04

(3000330) Specific gravity of Urine by Test strip

111

801

1.41

2.93

3.0

3.3

1.02

ratio

0.02

103

735

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

101

2.19

2.93

1.2

1.3

—

1005.56

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

213

1.80

2.93

1.5

1.4

396.50

362.81

pmol/l

0.15

184

(3037756) Immunofixation for Serum or Plasma

350

1.62

2.92

2.1

1.5

—

(3002179) Metamyelocytes/Leukocytes in Blood

192

1510

1.30

2.91

4.4

4.3

0.94

0.67

0.47

441

(4094501) Cardiovascular stress test using bicycle ergometer

479

1.52

2.88

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1745

16930

1.26

2.82

6.4

5.5

2.72

2.73

mmol/l

0.33

1670

15919

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.65

2.79

1.1

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

516

1.49

2.78

2.5

2.0

213.75

204.60

pmol/l

0.15

488

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

278

1.67

2.75

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

174

1.85

2.73

3.7

5.3

81.59

91.04

u/ml

0.05

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

111

2.08

2.73

1.1

1.0

312.59

281.32

ng/l

0.13

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

358

1.58

2.69

1.1

20.86

18.56

au/ml

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

586

5219

1.17

2.69

5.4

5.3

1.86

2.42

ug/l

1.71

538

4730

(3029634) Reagin Ab [Titer] in Serum by VDRL

311

1.62

2.68

1.7

2.1

—

9.33

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

112

2.07

2.67

1.1

1.0

42.33

40.75

ng/l

0.05

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

112

2.07

2.67

1.1

1.0

872.75

700.62

ng/l

0.86

(3003129) Base excess in Capillary blood by calculation

205

1.77

2.66

2.8

2.0

0.11

0.36

mmol/l

0.18

200

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

305

1.62

2.63

1.2

2.74

3.98

u/ml

0.30

114

(21494890) Protein electrophoresis panel - 24 hour Urine

155

1.88

2.61

2.6

2.1

—

(3008898) HLA-B27 [Presence]

100

725

1.40

2.60

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

3.34

2.60

1.8

2.8

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.20

2.57

1.5

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.20

2.57

1.5

1.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

4.01

2.56

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

142

1.91

2.56

4.0

2.5

15.24

33.26

mg/l

3.85

(3036670) Protein [Mass/volume] in Synovial fluid

2.74

2.54

1.1

1.2

38.80

38.12

g/l

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

5.47

2.54

1.0

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2.43

2.54

1.4

1.5

41.83

40.88

g/l

0.23

(44790049) Parainfluenza type 3 nucleic acid detection

247

1.67

2.50

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

247

1.67

2.50

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

247

1.67

2.50

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

247

1.67

2.50

1.5

—

(3003694) ABO and Rh group [Type] in Blood

594

5330

1.16

2.44

1.5

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

774

0.65

2.43

1.0

1.1

1.52

1.53

g/l

0.09

774

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

234

1.68

2.43

1.5

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

701

1.39

2.42

1.5

1.3

221.38

226.39

miu/ml

0.04

330

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

5.01

2.40

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

3.34

2.39

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

220

1.69

2.38

1.1

1.2

97.81

96.78

0.07

207

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1722

16741

1.22

2.35

5.7

4.9

4.62

4.64

mmol/l

0.36

1652

15820

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

299

1.59

2.34

1.3

1.2

3.70

5.12

u/ml

0.44

137

(3045424) Erythrocytes [Presence] in Urine

111

835

1.35

2.34

2.5

2.1

0.03

0.94

estimate

0.49

270

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

471

4172

1.17

2.27

4.4

20.39

21.47

0.76

211

1931

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1714

16665

1.21

2.27

5.6

4.8

1.41

1.45

mmol/l

4.02

1642

15640

(3026389) Candida sp identified in Specimen by Organism specific culture

231

1.66

2.27

1.2

1.3

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

797

0.67

2.27

1.1

1.2

0.90

0.89

g/l

0.08

797

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.28

2.24

1.5

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.28

2.24

1.5

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

319

1.55

2.23

1.4

1.7

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

352

1.52

2.21

1.4

1.5

0.22

0.36

nmol/l

2.20

276

(3032773) Endomysium IgG Ab [Titer] in Serum

195

1.70

2.19

1.0

1.1

—

(1002224) Polysomnography panel

123

950

1.31

2.18

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.25

2.17

1.4

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

4.30

2.15

1.0

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

4.30

2.15

1.0

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

320

0.50

2.14

1.4

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

174

1.74

2.13

1.4

1.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

275

1.58

2.12

1.3

—

(3044007) Cell count panel - Peritoneal fluid

2.46

2.10

3.0

2.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.21

2.09

1.0

1.1

—

(3007463) Buprenorphine [Presence] in Urine

5.01

2.07

12.2

3.6

—

(4268621) Lupus anticoagulant assay

215

1.64

2.04

2.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.41

2.02

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.09

2.01

1.0

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.51

2.01

1.1

1.2

—

(3014271) Vancomycin [Susceptibility]

2.23

2.01

2.6

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

2.64

2.00

1.0

1.1

—

(3025130) Human papilloma virus identified in Specimen

304

1.53

1.99

1.7

1.9

—

(3020876) Protein [Mass/time] in 24 hour Urine

194

1.66

1.97

2.9

2.5

0.84

1.25

g/24h

0.93

122

(3044242) Glucose [Moles/volume] in Arterial blood

1.95

1.8

2.5

7.33

8.28

mmol/l

0.67

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.36

1.95

1.1

—

(4212803) Bone marrow aspirate examination

4.55

1.94

1.0

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

4.55

1.94

2.0

4.2

—

(3038026) Centromere Ab [Units/volume] in Serum

127

1.82

1.94

1.1

1.2

—

86.13

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.76

1.93

1.0

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

195

1.65

1.93

1.4

1.6

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

282

1.54

1.93

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

219

1.61

1.91

1.1

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

158

1.72

1.89

1.5

1.3

34325.76

101592.00

e6/l

0.67

102

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.32

1.87

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.09

1.86

1.4

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

2.03

1.85

1.1

1.4

167.50

169.34

mmol/24h

0.03

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

285

1.52

1.85

1.2

115.76

115.18

0.03

262

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

144

1.75

1.85

1.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

392

1.44

1.85

1.2

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

401

1.43

1.84

1.4

1.6

—

(3002523) Influenza virus A Ag [Presence] in Specimen

393

1.44

1.83

1.2

1.1

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

183

1.65

1.82

1.7

1.6

59.55

57.34

0.12

116

(3037121) Protein [Mass/volume] in Urine

633

1.34

1.81

3.5

3.8

265.00

317.88

mg/l

0.28

297

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

3.34

1.74

1.2

1.4

1.00

1.06

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

3.34

1.74

1.2

1.4

1.72

0.72

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

3.34

1.74

1.2

1.4

1.41

1.23

mg/l

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.34

1.74

1.3

2.5

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.92

1.72

2.9

2.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.96

1.69

1.5

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.96

1.69

1.5

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.96

1.69

1.5

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.96

1.69

1.5

1.6

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

164

1.66

1.68

1.3

1.2

90.00

193.79

titre

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.16

1.66

1.0

1.3

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

3.16

1.66

1.2

1.5

0.76

0.86

mg/l

—

(37208534) Antinuclear antibody arbitrary concentration in serum

2.10

1.65

1.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

237

1.53

1.63

1.4

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

237

1.53

1.63

1.4

1.6

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.58

1.61

1.0

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

370

1.42

1.61

1.3

1.5

155.33

148.65

au/ml

0.12

105

(3017569) Oxygen content in Arterial blood

1.88

1.60

1.5

2.8

18.21

16.46

1.15

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.88

1.60

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.21

1.57

1.4

1.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.21

1.57

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

693

1.30

1.56

2.2

1.9

1.79

1.81

ug/l

0.01

617

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

131

1.69

1.49

1.7

1.4

164.19

229.42

pmol/l

0.41

131

(3012494) Peanut IgE Ab [Units/volume] in Serum

2.08

1.49

1.1

0.39

1.52

u/ml

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

446

1.36

1.46

1.2

1.3

—

56.01

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.51

1.45

2.7

2.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

3.13

1.44

1.2

1.0

0.41

7.73

u/ml

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.92

1.44

3.2

3.7

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.92

1.44

1.2

1.1

—

(3017509) Phencyclidine [Presence] in Urine

2.73

1.43

5.0

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.80

1.43

1.7

100.39

104.67

ng/l

0.10

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.18

1.40

2.0

3.3

5.02

4.99

kpa

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.18

1.40

2.0

3.3

10.02

10.60

kpa

—

(3042631) Mycobacterium sp identified in Specimen

222

1.49

1.39

2.4

2.6

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

264

1.45

1.37

1.8

1.9

—

1751.11

—

(40761536) Microorganisms panel - Urine sediment

170

1447

1.19

1.37

6.0

3.8

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

298

1.42

1.36

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

593

1.29

1.35

3.9

4.4

1.39

1.47

mg/l

0.40

548

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.87

1.34

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

1.33

0.0

1.2

—

69.15

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.00

1.32

0.0

1.1

—

19.63

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.50

1.30

2.5

1.7

—

(3052592) Norovirus Ag [Presence] in Stool

2.50

1.30

1.3

1.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

421

1.34

1.30

1.3

230.78

249.44

u/ml

0.22

253

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

459

1.32

1.24

1.2

1.1

1.48

2.25

u/ml

0.48

253

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

348

3150

1.13

1.24

3.3

3.2

0.61

0.75

ug/l

2.89

242

1955

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.91

1.22

1.9

1.6

121.83

94.04

nmol/24h

0.26

(3019832) Treponema pallidum Ab [Presence] in Serum

256

2278

1.14

1.19

1.7

1.8

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

109

1.66

1.19

1.6

2.9

411.33

1028.05

u/ml

1.89

109

(3038177) Helicobacter pylori Ab [Presence] in Serum

300

1.37

1.15

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

167

1.50

1.12

4.6

3.6

—

(4195642) Thrombophilia screening test

276

1.38

1.12

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

119

1.60

1.11

1.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

168

1.49

1.10

1.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.19

1.08

1.3

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1109

0.82

1.07

1.5

1.6

1052.31

1009.59

mu/l

0.18

938

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

477

0.73

1.07

1.6

1.8

—

(3011897) Casein IgE Ab [Units/volume] in Serum

2.13

1.05

1.0

1.3

0.05

0.88

u/ml

—

(3032057) Clostridioides difficile [Presence] in Stool

2.13

1.05

1.6

2.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

212

1.42

1.04

1.2

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

1.67

1.04

1.9

1.8

3.47

3.80

nmol/l

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.28

1.03

5.6

5.9

5.16

6.13

mmol/l

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.28

1.03

2.6

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

2.28

1.03

3.0

3.5

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.06

1.03

1.6

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.06

1.03

1.6

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.06

1.03

1.6

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.84

1.03

1.4

1.1

—

(3047189) Immunofixation for 24 hour Urine

1.74

1.02

2.6

1.7

—

(4035726) Immunohistochemistry procedure

167

1460

1.16

1.02

1.4

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

1.92

1.02

2.0

—

177.47

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

414

0.72

1.00

1.3

1.6

55.60

56.93

ug/l

0.06

414

(3028717) Thiamine [Mass/volume] in Blood

2.00

1.00

1.0

1.3

63.00

66.94

ug/l

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

220

1965

1.13

0.99

5.3

4.7

32.45

31.85

0.37

163

1363

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

115

1.57

0.99

2.2

2.9

44.78

43.12

0.14

(3023199) Leukocytes [#/volume] in Pleural fluid

189

1.43

0.99

1.6

1.4

3946.00

1637.27

e6/l

0.43

128

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

353

1.31

0.98

1.5

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.18

0.98

1.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

140

1.51

0.97

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.95

0.97

1.1

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

267

1.35

0.96

1.7

1.6

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.69

0.95

1.6

2.8

21.14

124.08

ug/l

0.48

(3004959) Base excess in Arterial cord blood by calculation

0.00

0.95

0.0

1.0

—

-3.66

—

(3006598) pH of Arterial cord blood

0.00

0.95

0.0

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

722

0.80

0.94

1.3

1.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

229

2062

1.13

0.92

1.7

—

(4034850) Laboratory test

519

1.24

0.90

10.3

9.7

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.07

0.89

1.2

2.8

—

7583.33

—

(4015189) Microbial culture of sputum

1.91

0.88

2.8

3.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

197

1.38

0.82

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

400

1.26

0.81

1.1

6.86

4.86

u/ml

0.51

231

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

294

1.30

0.80

1.5

1.4

19.04

21.39

u/l

0.24

245

(3034426) Prothrombin time (PT)

1.73

0.79

1.1

1.3

28.60

28.28

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

286

1.30

0.79

3.8

3.4

0.83

0.85

nmol/l

0.11

234

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

411

1.25

0.78

6.2

5.8

1249.43

323.77

iu/ml

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.00

0.78

0.0

1.3

—

(40768446) Kidney Pathology biopsy report

1.63

0.78

1.5

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

528

0.79

0.77

1.5

1.6

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

333

1.27

0.75

1.2

1.1

6.06

4.66

u/ml

0.26

177

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.09

0.74

1.8

2.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

210

1.34

0.74

1.6

1.5

30.77

31.94

g/l

0.19

187

(3000034) Microalbumin [Mass/volume] in Urine

133

1.43

0.73

2.3

3.3

5.17

44.33

mg/l

1.92

100

(44813793) Dust mix specific IgE antibody measurement

133

1.43

0.73

1.1

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.84

0.73

1.4

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

108

1.49

0.73

1.1

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.00

0.72

3.2

3.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.80

0.72

1.1

14.34

45.69

iu/ml

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

299

1.28

0.72

1.2

1.1

—

1.25

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

308

1.27

0.72

1.1

10.07

5.39

u/ml

0.43

144

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.67

0.72

1.1

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

135

1.41

0.69

1.3

1.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

110

1.46

0.68

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

153

1.38

0.67

2.7

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

384

1.23

0.67

1.2

1.1

3.38

1.59

u/ml

0.72

204

(3024263) Appearance of Synovial fluid

1.52

0.66

1.1

1.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

1.54

0.65

1.0

4.8

65.57

78.60

mg/l

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

163

1.35

0.64

1.6

1.4

9464.07

29900.62

e6/l

1.33

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

112

1.43

0.63

1.2

1.1

1691.44

1565.57

miu/ml

0.15

112

(3012441) Differential panel - Pleural fluid

164

1.35

0.62

1.5

1.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.59

0.61

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.59

0.61

1.6

—

(3045788) Cell count panel - Pleural fluid

156

1.35

0.61

1.6

1.4

—

(4146454) Self-monitoring of blood glucose

165

1.34

0.60

3.1

2.7

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.60

0.0

1.1

—

162.05

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.60

0.0

1.4

—

5.83

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.57

0.58

1.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

431

1.19

0.55

1.4

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.50

0.54

1.4

1.5

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

151

1.33

0.54

1.6

1.7

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

386

1.20

0.53

2.6

2.2

0.93

0.89

nmol/l

0.12

328

(3004451) EKG impression Narrative

108

1.39

0.53

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.54

0.53

1.5

1.4

—

(3044927) Protein electrophoresis panel - Urine

170

1.30

0.51

1.2

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

388

1.19

0.51

1.1

0.42

1.18

u/ml

1.33

174

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

109

1.38

0.51

1.3

1.1

—

(3006462) Nitrate [Presence] in Urine

1.50

0.49

1.4

2.9

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

625

0.86

0.49

1.5

58.40

60.54

ug/l

0.14

534

(3002619) Bacteria identified in Specimen by Culture

1.56

0.49

1.0

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

290

1.21

0.47

1.1

1.0

0.14

0.22

u/ml

0.21

104

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

128

1.33

0.47

2.2

0.67

1.88

u/field

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

102

1.38

0.47

1.2

1.5

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

266

0.79

0.47

4.3

4.2

32.39

30.70

u/ml

0.05

258

(40758292) HTLV I+II Ab panel - Serum

1.56

0.42

1.2

1.4

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

1.52

0.41

1.2

3.6

58.00

74.26

—

(40757373) Influenza virus identified in Isolate

1.52

0.41

2.0

1.7

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

277

1.19

0.41

1.1

1.88

2.29

eliau/ml

0.27

127

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

105

1.34

0.41

1.2

1.5

—

(3048879) Bone marrow aspiration report

1.47

0.40

1.0

1.9

—

(3036782) Glucose [Moles/volume] in Pleural fluid

168

1.25

0.40

1.6

1.4

5.87

6.54

mmol/l

0.61

157

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.40

0.0

1.1

—

1.43

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.31

0.39

1.8

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.34

0.39

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.34

0.39

1.6

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

1.43

0.39

1.6

1.3

39.80

23.15

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.39

0.38

2.2

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

179

1.23

0.37

1.8

2.5

36.11

21.35

mg/l

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

224

0.80

0.37

1.3

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

171

1.23

0.35

1.1

1.3

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

153

1.24

0.35

2.1

2.5

533.16

1197.06

1.39

153

(3018133) Calcium [Moles/volume] in Urine

1.36

0.34

1.3

2.4

1.86

3.09

mmol/l

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

647

0.89

0.34

1.4

1.5

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.31

0.33

1.2

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.31

0.33

4.0

3.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.70

0.33

1.0

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

303

1.16

0.33

1.4

1.2

67.55

33.90

u/l

0.57

256

(3008757) Leukocyte morphology finding [Identifier] in Blood

173

1.22

0.33

3.4

3.7

—

(3022689) Creatine [Moles/volume] in Urine

1.28

0.32

2.2

1.3

8.95

8.36

mmol/l

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

119

1.26

0.31

1.2

1.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

296

1.15

0.30

1.1

1.4

2.99

4.18

ug/l

0.65

270

(4211845) Urine protein measurement

1.34

0.30

1.4

2.7

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

1.31

0.30

1.3

1.1

—

5.20

—

(3020491) Glucose [Moles/volume] in Blood

121

1.24

0.28

1.8

2.2

6.84

6.67

mmol/l

—

(40768795) Lymph node Pathology biopsy report

167

1.20

0.28

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.25

0.27

2.6

1.2

—

(4281824) Cell count and differential, peritoneal fluid

168

1.19

0.27

1.4

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

122

1.23

0.27

1.1

0.80

1.53

u/ml

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

614

0.91

0.26

1.4

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1007

0.93

0.26

1.7

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

722

1.08

0.26

1.4

1.8

4.08

4.65

mg/l

0.20

524

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.30

0.26

2.6

3.8

1.10

1.14

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

132

1.21

0.25

1.4

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

133

1.20

0.24

1.5

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

1.28

0.24

1.3

1.1

83.90

92.37

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

579

0.91

0.24

1.4

1.5

0.95

ratio

0.00

370

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

579

0.91

0.24

1.4

1.5

1.50

1.19

ratio

0.92

370

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

579

0.91

0.24

1.4

1.5

1.16

1.13

ratio

0.08

370

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

568

0.91

0.23

1.4

1.5

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

0.75

0.22

1.3

1.2

4.71

9.52

mm/h

—

(3036048) Francisella tularensis Ab [Titer] in Serum

1.25

0.22

1.2

1.1

—

(3045142) Bone marrow Pathology biopsy report

200

1.15

0.22

1.3

1.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.27

0.22

1.1

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.2

—

187.91

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.21

0.0

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.21

0.0

1.5

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.21

0.0

5.7

—

(3022670) pH of Venous cord blood

0.00

0.21

0.0

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.21

0.0

4.0

—

99.54

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.00

0.21

0.0

1.4

—

(40768800) Prostate Pathology biopsy report

326

1.11

0.20

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

490

0.92

0.20

1.5

1.6

—

(3028433) Virus identified in Specimen by Culture

1.20

0.19

1.3

1.4

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

109

1.19

0.18

1.1

1.0

0.12

0.31

u/ml

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

147

1.16

0.18

1.2

1.1

—

(21494434) Karyotype in Bone marrow

153

0.85

0.18

1.5

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

378

1.09

0.17

2.1

2.4

208.43

105.48

ug/min

0.34

235

(3042733) HLA Ab [Presence] in Serum

0.75

0.17

2.8

4.7

—

(3020650) Glucose [Presence] in Urine

0.73

0.17

1.8

1.7

0.00

0.04

estimate

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

612

1.06

0.16

2.4

3.6

1056.48

2388.82

u/ml

0.36

532

(44806420) Estimation of glomerular filtration rate

203

0.89

0.15

2.2

2.3

—

(3000012) Reticulocyte production index

226

1.11

0.15

1.6

2.2

1.00

0.93

0.21

148

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

102

1.18

0.15

2.0

1.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

141

1.14

0.14

1.1

105.25

107.65

pmol/l

0.10

141

(3003329) Lymphocytes/Leukocytes in Synovial fluid

141

1.14

0.14

2.1

1.4

45.33

31.10

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.83

0.13

1.1

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

479

0.94

0.13

1.5

—

(3005033) Fetal Nuchal fold Thickness US

467

0.94

0.12

1.4

1.5

1.24

1.27

0.13

341

(3020874) Milk IgE Ab [Units/volume] in Serum

124

1.13

0.11

1.1

0.76

2.55

u/ml

—

(3023383) Lactate [Moles/volume] in Pleural fluid

1.14

0.10

1.2

1.5

2.52

3.58

mmol/l

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.11

0.09

2.2

1.4

12.57

9.10

ug/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

292

2879

1.02

0.08

1.5

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.84

0.07

1.0

—

(40768441) Liver Pathology biopsy report

137

1.10

0.07

1.5

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

227

2301

0.98

0.06

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

306

1.05

0.05

1.3

1.2

—

(3005570) Glucose [Moles/volume] in Urine

179

1.06

0.05

5.1

2.2

—

(3017704) Immunofixation for Urine

1.10

0.04

2.0

1.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

129

0.93

0.03

1.0

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

149

1.01

0.00

1.6

1.3

307.73

381.45

u/l

0.32

144

(3051387) C reactive protein [Mass/volume] in Capillary blood

345

1.01

0.00

4.0

3.7

19.72

25.53

mg/l

0.39

242

(1761482) Bacteria [#/volume] in Urine by Culture

355

0.99

0.00

4.0

4.4

—

(40768806) Pleura Pathology biopsy report

156

1.03

0.00

1.8

1.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

238

1.01

0.00

1.2

1.1

—

(40768793) Breast Pathology biopsy report

407

1.01

0.00

1.3

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

0.00

0.0

1.0

—

0.05

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.1

—

7.83

—

(4133840) Spirometry

1.00

0.00

1.2

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.6

—

1.54

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

26.50

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

1.0

—

4.56

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3013637) Mi-2 Ab [Presence] in Serum

0.98

-0.00

1.2

1.1

—

(3024932) HLA-DR beta [Type]

0.88

-0.00

1.0

1.1

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.89

-0.00

1.0

1.1

292.86

200.70

iu/ml

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

(3024471) HLA-A [Type]

0.86

-0.00

1.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

-0.00

0.0

1.0

—

69.10

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.98

-0.00

1.3

1.5

0.60

0.48

e9/l

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

9.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.98

-0.00

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.98

-0.00

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.98

-0.00

1.2

1.1

—

(3026820) Hemoglobin [Mass/volume] in Venous cord blood

0.00

-0.00

0.0

1.0

—

177.80

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

161

1610

1.00

-0.00

3.5

4.4

5.25

18.80

ug/l

1.65

124

1295

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.85

-0.00

1.2

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.00

-0.00

1.1

1.2

—

913.33

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

-0.00

0.0

1.0

—

39.94

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: R18_CRAMP_SPASM – Cramp and spasm

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Cramp and spasm

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Cramp and spasm (R18_CRAMP_SPASM)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints